{
  "name" : "twin.sci-hub.se_6502_06836ee4a4ac3192c3b7e53d3df4f7a7_teradal2017.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "Carbon Nanomaterials in Biological Studies and Biomedicine",
    "authors" : [ "Nagappa L. Teradal", "Raz Jelinek" ],
    "emails" : [ "razj@bgu.ac.il" ],
    "sections" : [ {
      "heading" : null,
      "text" : "www.advhealthmat.de\nREVIEW\n1700574 (1 of 36) © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim\nCarbon Nanomaterials in Biological Studies and Biomedicine\nNagappa L. Teradal and Raz Jelinek*\nDOI: 10.1002/adhm.201700574"
    }, {
      "heading" : "1. Introduction",
      "text" : "Carbon nanostructures have had a tremendous impact in scientific research and technology progress. The unifying property of zero-dimension fullerenes,[1] one dimensional carbon nanotubes (CNTs),[2] the two-dimensional carbon allotrope graphene[3] and recently synthesized carbon quantum dots[4] is the sp2-bonded carbon atoms that are generally arranged in hexagonal lattices. These features, combined with the interesting electrical, chemical, and mechanical properties of carbon nanomaterials, have led to numerous applications in diverse fields. The potential of carbon nanomaterials in biology–e.g., as conduits for biosensing, bioimaging, and as novel biomimetic materials–has been recognized early on. While carbon nanomaterials have been initially used in biosensing and as potential drug carriers, recent years saw expansion of their applications into regenerative medicine, tissue engineering, bioimaging, and therapeutics. Reviews discussing biological applications of CNTs,[5] graphene,[6] and carbon quantum dots[7,8] have been published.\nThis Review focuses on biologically oriented applications of the three main families of carbon nanostructures–CNTs, graphene (pristine graphene, graphene oxide, and reduced graphene oxide), and carbon quantum dots. Figure 1 presents an outline of the contents of this Review article. Our goal is to provide a broad overview of the diverse applications of these nanomaterials, emphasizing the significance of their respective\nThe “carbon nano-world” has made over the past few decades huge contributions in diverse scientific disciplines and technological advances. While dramatic advances have been widely publicized in using carbon nanomaterials such as fullerenes, carbon nanotubes, and graphene in materials sciences, nano-electronics, and photonics, their contributions to biology and biomedicine have been noteworthy as well. This Review focuses on the use of carbon nanotubes (CNTs), graphene, and carbon quantum dots [encompassing graphene quantum dots (GQDs) and carbon dots (C-dots)] in biologically oriented materials and applications. Examples of these remarkable nanomaterials in bio-sensing, cell- and tissue-imaging, regenerative medicine, and other applications are presented and discussed, emphasizing the significance of their unique properties and their future potential.\nCarbon Nanomaterials\nDr. N. L. Teradal, Dr. R. Jelinek Department of Chemistry and Ilse Katz Institute for Nanotechnology Ben Gurion University of the Negev Beer Sheva 84105, Israel E-mail: razj@bgu.ac.il\nunique properties. Due to the breadth of this field and considerable volume of research papers published we discuss below fraction of the (recent) literature on the subject, and readers are encouraged to expand their knowledge further on specific topics. Overall, we hope that this Review would highlight the significant contributions of carbon nanomaterials to biological research, and their potential for future scientific and technological developments.\n2. Carbon Nanotubes and their Derivatives\nCarbon nanotubes [abbreviated CNTs; also categorized as single-walled carbon nanotubes (SWCNTs) or multi-walled carbon nanotubes (MWCNTs), Figure 2] have been among the early members in the “carbon nanotechnology” universe. The remarkable properties of CNTs, including high tensile strength, mechanical flexibility, and electrical conductivity, have attracted significant scientific and technological interest; Indeed, CNTs are already employed in varied products. Biological applications of CNTs, in particular, have been touted and explored mostly due to the diverse surface chemistry modification pathways enabling attachment of recognition elements and biomolecular cargoes to the nanotubes. These features have opened the way for applications in biosensing, drug delivery, and tissue engineering, discussed below.\nA notable aspect of CNTs, which adversely affects their biological applicability is their low solubility in aqueous solutions. Specifically, CNTs exhibit high affinity towards agglomeration, mostly due to strong surface interactions. Dispersion of CNTs can be achieved either by covalent or non-covalent modification of their surfaces. Enhanced dispersion of CNTs in aqueous solvents can be accomplished through non-covalent functionalization with biocompatible conjugates such as phospholipid-polyethylene glycol.[9] Attachment of amphiphilic small molecules and polymers has been also reported.[10] Noncovalent functionalization of CNTs is particularly useful as this treatment does not disrupt the carbon lattice, thus generally preserving the physico-chemical properties of CNTs. Ideally, noncovalent functionalization should provide higher water solubility, biocompatibility, stability in various biological solutions and functional groups that are available for further bioconjugation.[9]"
    }, {
      "heading" : "2.1. CNT-Based Biosensors",
      "text" : "CNTs have been a focus of intensive research as conduits for biosensing applications due to their extensive surface onto\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (2 of 36)\nwhich recognition elements and capture agents can be displayed for detection of biological species. In general, CNTbased biosensors exhibit important advantages, such as high surface area-to-volume ratio, feasibility of immobilizing varied recognition molecules without adversely affecting their biological functions, and fast response times as CNTs can efficiently mediate electron transport processes. Moreover, CNTs exhibit high stability and low surface fouling over time, contributing to practical biosensing applications.[11,12]"
    }, {
      "heading" : "2.1.1. Glucose Biosensor",
      "text" : "Enzyme-based CNT biosensors have been widely reported. The most common enzyme-based biosensor is the glucose sensor, mostly targeted towards monitoring glucose levels in the blood of diabetic patients. Figure 3 depicts the most ubiquitous glucose sensing mechanism. A glucose-specific enzyme, glucose oxidase (abbreviated as GOx) catalyzes glucose oxidation (i.e., transformation of glucose to gluconolactone). In this process, the enzyme’s redox cofactor, flavin adenine mononucleotide (FAD) is converted to its reduced form flavin adenine dinucleotide (FADH2). The process by which the reduced form of the enzyme is converted back to its oxidized state occurs through direct electron transfer from the working electrode, and the obtained electrochemical signal can be related to glucose content (Figure 3).[13]\nCNTs in glucose sensing have been mostly used as conduits for electron transport, e.g., as conductive nanowires. Patolsky et al. demonstrated the use of SWCNTs as electrical linkers between the enzyme (FAD) redox centers and the electrodes,[14] in which sensing relied upon the direct electron transfer mechanism (Figure 4a). FAD was first covalently attached to the SWCNT terminus, and GOx was subsequently reconstituted upon the immobilized FAD (Figure 4a). In this system, the SWCNTs acted as effective electrical nano-connectors, linking the active site of the enzyme and the electrode surface. In particular, this arrangement enabled electron transport over relatively long distances (>150 nm), while the rate of electron transport was controlled by the length of the SWCNTs. The results of this study revealed the compatibility of SWCNTs with the preparation of novel biomaterial hybrid systems that can be used as biosensing platform for glucose.\nFigure 4b outlines another glucose sensor design in which CNTs enhanced electron transfer in a GOx-based sensing platform.[15] The basic assembly comprised of enzyme precipitate\ncoating electrode (EPC-E) in which enzyme immobilization enabled the sensitive detection of glucose. The CNTs in that system constituted useful substrates for enzyme coating and also as conduits of electron transport. Notably, significantly enhanced sensitivity (≈7-fold) and charge transfer rate were achieved in a setup that combined EPC-E with CNTs (Figure 4b). The greater sensitivity in the composite EPC-E/CNT was ascribed to the CNTs acting as an “electron transport highway” to increase the efficiency of electron movement from the enzyme active sites to the electrode surface.[15]\nNagappa L. Teradal received his Ph.D. in Chemistry in 2015 from the Karnatak University, Dharwad, India, under the supervision of Prof. J. Seetharamappa. He is currently a postdoctoral research associate with Prof. Raz Jelinek in the Department of Chemistry at Ben-Gurion University of the Negev, Beer Sheva, Israel. His research\nfocuses on the development of advanced nanostructures for various technological applications, especially sensing and catalytic applications.\nRaz Jelinek holds the Carole and Barry Kaye Chair in Applied Science at the Department of Chemistry, Ben Gurion University, and is also a founding member of the Ilse Katz Institute for Nanoscale Science and Technology (IKI). Prof. Jelinek’s research is broad-based, and he has worked in varied fields\nincluding “bottom-up” chemistry, bio- and chemo-sensors, amyloid peptides, membranes, and carbon nanoparticles.\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (3 of 36)\nGlucose biosensors based on CNT nanocomposites comprising metal oxide nanoparticles were also reported. Figure 4c depicts the backbone of a GOx/MnO2/MWCNT sensor.[16] The presence of the MnO2 nanoparticles on the surface of the CNTs enhanced the enzymatic activity and reversibility of the GOxmediated redox processes, in turn enhancing the sensitivity and stability of the electrochemical glucose biosensor. Similar composite sensors comprising MWCNT/ZnO/GOx,[17] MWCNT/ Au/GOx,[18] and MWCNTs/gold colloid/poly diallyldimethylammonium chloride) (PDDA)[19] were also reported."
    }, {
      "heading" : "2.1.2. Acetylcholine and Organophosphates Biosensing",
      "text" : "CNTs were also employed as core sensor elements for detection of organophosphates (OPs) affecting neurotransmitters such as acetylcholine (ACh). ACh plays an important role in communicating between motor nerves and muscles, especially in the heart, bladder, and stomach.[20] OPs, mostly used as pesticides, are highly toxic to humans as they inhibit the activity of the enzyme acetylcholine esterase (AChE) leading to accumulation of acetylcholine, which may lead muscular paralysis, convulsions, bronchial constriction, and even death by asphyxiation.[21] Figure 5 depicts CNT-based AChE biosensors facilitating sensitive detection of both OPs and Ach. Specifically, CNTs functioned as an excellent conductive support between the enzyme and electrode surface, enhancing the electrochemical reactivity\nand stability of the enzyme (AChE). CNT surfaces in particular have been amenable for immobilization of AchE, without adversely affecting its functionality.[20–24]\nDifferent CNT-based supports, Au-MWCNTs/GCE,[22] and MWCNTs/Nanoporous gold electrode (linked through cysteamine)[23] were also used to immobilize the bio-recognition layer comprising AChE for selective sensing of OPs. Notably, the high sensitivity of those sensors for OPs was ascribed to enhanced electrochemical response of the composite electrode affected by the excellent bioactivity of the immobilized enzyme. In other reported schemes, CNTs were interspersed within conductive polymers (CPs) which synergistically enhanced AChE bioactivity and sensor performance.[24] CNT-based sensors were employed for detection of many other biomolecular targets, including galactose,[25] neurotransmitters (dopamine,[26] epinephrine,[27] and norepinephrine[28]), amino acids (i.e., glutamic acid,[29] D- and L-amino acids[30]), immunoglobulins,[31] albumin,[32] and others."
    }, {
      "heading" : "2.1.3. DNA Biosensors",
      "text" : "CNTs have been also coupled to deoxyribonucleic acid (DNA) for sensing applications. DNA-based sensors have been widely used in medical diagnostics, forensic science, and other applications.[12] The core sensing elements in DNA biosensors are either single stranded DNA (ssDNA) or double stranded (dsDNA), which constitute the biological recognition layers.\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (4 of 36)\nResearchers have found that DNA efficiently adsorbs onto CNT surfaces and forms supramolecular complexes which consequently benefit from both the distinctive properties of the nanotubes and the outstanding recognition capabilities of DNA.[33] DNA-coupled CNTs exist as well-defined chemical entities in aqueous solutions due to the strong non-covalent interactions between DNA and the CNTs.[33] As shown in Figure 6, DNA can “coil” around CNTs, or binds either onto the basal or the side surface. Functionalization of CNTs with DNA also contributes to greater CNT solubility thus increasing practicality of composite materials as sensors.[34] DNA-CNT hybrids have been used as biosensors for detection of varied analytes, including peroxide,[35] dopamine,[36] proteins[37] and others.\nCNT-DNA conjugates have been employed for detection of specific oligonucleotide sequences. In most such systems ssDNA has been used as probe, designed to hybridize complementary target DNA.[32–39] The sensitivity, specificity, and stability of CNT-DNA sensors could be enhanced by further conjugating the hybrid with reduced graphene oxide (rGO)[38] or CuO nanowires.[39] These additives are believed to accelerate electron transport properties of the hybrid materials. Similarly, MWCNTs functionalized with methylene blue (MB) enabled sensitive electrochemical detection of DNA.[40]\nIn yet another study, Zhao et al. developed a sensing platform based on MWCNT signal amplification and fluorescence polarization (FP) for sensitive and selective detection of DNA methyltransferase (DNA MTase) activity (Figure 7).[41] This assay uses a fluorescein amidite (FAM)-labeled DNA probe, which contains a dsDNA part to serve as the specific recognition sequence of both DNA MTase and its corresponding restriction\nendonuclease, and a ssDNA component for anchoring the DNA to the surface of MWCNTs. In the absence of DNA MTase, this FAM-labeled DNA probe is cleaved by restriction endonuclease, and generates the very short DNA fragments carrying the FAM dye that cannot bind to the MWCNTs. In this situation, the FAM dye exhibits relatively small polarization. However, in the presence of DNA MTase the specific recognition sequence within the FAM-labeled DNA probe is methylated and blocked the cleavage by its corresponding restriction endonuclease. Thus, the FAMlabeled methylated DNA product was adsorbed onto CNTs via strong π–π stacking interactions leading to significant increase in polarization due the slow rotation of the DNA/MWCNT complex."
    }, {
      "heading" : "2.1.4. Cancer Biomarker Detection",
      "text" : "Sensors designed to report on specific molecular cancer markers are highly sought for as “early warning” agents in cancer diagnostics. Different classes of CNT biosensors have been developed to detect a wide variety of cancer biomarkers through conjugation with aptamers (oligonucleotide sequences employed for biomolecular recognition,[42] antibodies, peptides, proteins, and enzymes).[43,44] In particular, CNTs have been shown to promote electron transfer reactions involving proteins and enzymes.[45] Figure 8 outlines a generic experimental scheme for detection of cancer markers by CNT-immobilized antibodies (Abs).[46] The transduction principle in such systems is based upon modulation of the electrical current flowing through the CNTs, induced upon binding of cancer antigens to the Abs immobilized upon the CNTs’ surface.[47]\nResearchers reported use of antibodyfunctionalized CNTs for detection of varied cancer biomarkers. A nanostructured CNT “forest” was constructed for ultrasensitive detection of interleukin-6 (IL-6), a multifunctional cytokine characterized as a regulator of immune and inflammatory responses, in serum of disease-free and cancer patients.[48] The immunosensor comprised of an electrically conductive, high surface area substrate featuring densely packed, upright SWCNTs mimicking a “forest” onto which ends specific antibodies (Ab1) were attached. Antigens were bound to the Ab1 molecules, subsequently detected by an enzyme-bound secondary\nAdv. Healthcare Mater. 2017, 1700574\nFigure 6. Wrapping of single stranded (ss)/double stranded (ds) DNA on CNT surface. Shown are non-covalent (left) or covalent (middle and right) modification of CNTs with ss/ds DNA.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (5 of 36)\nantibody. Antibody-loaded MWCNTs facilitated simultaneous detection of the cancer biomarkers prostate specific antigen (PSA) and Interleukin 8 (IL-8).[49]\nA different strategy for CNT-based cancer detection was reported in which electrochemical impedimetric immunosensing for cancer biomarkers was accomplished using CNTs modified with Au NPs.[50] In the system, the Au NPs rather than the CNTs functioned as protein-immobilization surfaces. Ultrasensitive chemo-resistive biosensors comprising single MWCNTs embedded in epoxy nanofibers and further displaying monoclonal antibodies (mAbs) for human cardiac biomarkers such as myoglobin, cardiac Troponin I, and creatine kinase were reported.[44] CNT field-effect transistor (FET) sensors have been recently demonstrated. A case in point is a study depicting detection of the cancer marker osteopontin (OPN).[51] In this method, a genetically engineered OPN-binding protein was covalently bound onto the surface of CNTs, displaying OPN concentration-dependent modulation of source–drain currents. Introduction of “defect sites” upon the CNT sidewalls increased OPN sensitivity through electron scattering. Another strategy achieved sensitive voltammetric detection of cancer cells using vertically aligned MWCNTs which enabled entrapment of cancer cells. Mechanical and electrical interactions between the CNT tips and entrapped cell membranes modulated the system electrical potential.[52,53] The MWCNTs were termed “cellular\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (6 of 36)\ncancer endoscopes” reporting on the electrical signals produced by single cell membranes.[52]"
    }, {
      "heading" : "2.2. CNTs in Drug and Gene Delivery",
      "text" : "CNT-based drug delivery systems have been explored for treatment of a variety of diseases, primarily cancer therapy. Two main strategies have been pursued: selective targeting accomplished through functionalization of CNT surfaces with specific tumor recognition elements, and CNT-mediated controlled release of drugs in tumor environments.[54,55] CNTs have been shown to deliver small amounts of drugs to specific tumor sites, thus minimizing systemic toxicity and reducing undesirable side-effects. Chen et al. constructed peptide-modified SWCNTs through a noncovalent approach which were further loaded with the anticancer drug tamoxifen (TAM).[56] This system was tested in vitro and in vivo and showed efficient tumor targeting and high antitumor activity. Functionalized MWCNTs have been used for targeting cancer cell nuclei and releasing the common anticancer drug doxorubicin (DOX).[57] Several studies reported dye-labeling or radioactive-labeling of CNTs to track the release, location, and movement of drugs inside the cell.[58,59]\nThe release of drug cargo from CNTs at delivery sites is a major challenge in CNT-based drug delivery. pH-induced release of DOX from SWCNTs was reported and evaluated through a two-dye approach (Figure 9a).[59] The SWCNTs were first labeled with fluorescein isothiocyanate (FITC) emitting at 520 nm, while DOX was separately labeled with a red dye emitting at 590 nm. Confocal microscopy was then applied to track the location of both SWCNTs and DOX cargo. Notably, release of the drug molecules from the SWCNTs took place in the lysosomes, with subsequent migration into the cytoplasm\nand finally into the nucleus. The SWCNT carriers, on the other hand, remained in the lysosomes.\nBandyopdhyay et al. reported controlled release of various anti-inflammatory[60] and anti-anginal drugs[61] from nanocomposite membranes comprising CNTs (Figure 9b). Controlled drug release was achieved by tuning the hydrophobic characteristics of a polymer matrix. Essentially, water-induced swelling led to faster release of the encapsulated drug while slower swelling retained the drug for longer duration within in the polymer matrix. Bandyopdhyay and co-workers used varied concentrations of differently functionalized CNTs to tune the hydrophobic characteristics of the polymer nanocomposite and thus the swelling properties.[60,61] Similarly, Pal and co-workers developed carboxymethyl cellulose (CMC) and acid-functionalized MWCNTs which formed biodegradable nanocomposite hydrogel for the sustained release of diclofenac sodium.[62] Notably, ∼98% of the diclofenac sodium molecular cargo was not decomposed over time in the release system upon the incorporation of MWCNTs.[62] pH- and temperature-induced controlled release system, polyethyleneglycol (PEG)-functionalized MWCNTs for cancer therapy were reported.[63] That study also showed biocompatibility of the conjugated particles and efficient delivery of the therapeutic compound to tumor cells.\nSWCNTs non-covalently coupled to DOX and further functionalized with a tumor-specific ligand (folic acid) shown to exhibit controllable loading/release of DOX as well as selective killing of tumor cells.[55] Following binding to the cell-surface folate receptor, the SWCNTs–ligand complex was cell-internalized through endocytosis. Inside the endosomes, higher acidity induced release of DOX from the SWCNTs, resulting in effective tumor inhibition.[55] In another study, an electroresponsive poly(methylacrylic acid) (PMAA)-based hydrogel matrix containing pristine MWCNTs was assembled for pulsatile drug release.[64] In this system, low electric field was applied for a\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (7 of 36)\nshort duration to induce disintegration of the hydrogel and consequent drug release; the incorporated CNTs aided the electrical stimulation and drug release.[64]\nCNTs have also contributed to the burgeoning research in gene therapy. Therapeutically active oligonucleotides, including plasmid DNA (pDNA), small hairpin RNA (shRNA) smallinterfering RNA (siRNA) and micro-RNA (miRNA), have all been used to either overexpress or inhibit expression of target proteins.[65] In particular, functionalization of CNTs with cationic groups has enabled delivery of negatively charged DNA into cells. In contrast to this well-known strategy for DNA delivery, other reported approaches utilized covalent attachment of linear pDNA to carboxylated MWCNTs.[66] The resulting bioconjugate was successfully transported into Escherichia coli cells and the transformed cells able to express green fluorescent protein, inspected manually on ampicillin agar plates.\nDNA (e.g., gene) delivery is not only the most important but also the most problematic aspect of gene therapy. CNTs were applied for combined gene and drug delivery into human gastric cancer cells (Figure 10).[67] Synergistic cancer cell death was achieved by a targeted delivery system comprising B-cell plasmid lymphoma-extra-large (pBcl-xL)-specific shRNA and a very low DOX content, which simultaneously activated an\nintrinsic apoptotic pathway. Specifically, modified branched polyethylenimine (PEI) was grafted through a polyethylene glycol (PEG) linker to carboxylated SWCNTs. The SWCNTPEG-PEI conjugate was covalently attached to an aptamer targeting overexpressed nucleolin receptors on tumor cell surface and loaded with the therapeutic drug DOX. Overall, this system revealed that a combination of shRNA-mediated genesilencing strategy with chemotherapeutic agents constituted a valuable and safe approach for antitumor activity.[67] Similar positively charged functionalized polymeric units on CNTs were employed for docking genes and deliver them to cellular targets.[67,68] SWCNTs were also conjugated to small interfering RNA (siRNA) designed as a vehicle for gene therapy of pancreatic cancer.[69]\nRecent studies have shown effective protein delivery into cells through coupling with CNTs. Chen et al. conjugated SWCNTs with therapeutic proteins[70]; the SWCNTs in that system served both as nanocarriers for the protein cargo as well as photothermal agents – generating heat following illumination with near infrared (NIR) light, cleaving the proteinnanotube bond, and releasing the protein. This strategy was demonstrated for delivery and NIR-activation of a therapeutic protein, saporin in living cells (Figure 11).[70] The activity of\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (8 of 36)\nthe proteins attached onto the SWCNTs was inhibited due to steric hindrance. However, once inside the cells, NIR irradiation cleaved the linkage between the protein cargo and SWCNTs. The released proteins became active and performed their cellular functions.\nOhta and co-workers have developed another multifunctional CNT-based carrier platform for drug and gene delivery.[71] In this particular system, the researchers PEGylated SWCNTs that were further modified with the cationic amphiphilic peptide, H-(-Lys-Trp-Lys-Gly)7-OH [denoted as (KWKG)7]. This treatment improved the solubility and stability of the composite in cell cultured medium.[71] The PEGylated peptide-functionalized SWCNTs displayed an extensive surface that could be employed for immobilizing of gene cargo.[71] Other examples of CNTassisted protein delivery into cells were reported.[72]"
    }, {
      "heading" : "2.3. CNTs in Photoacoustic Imaging and Phototherapy",
      "text" : "Photoacoustic imaging is a new tissue imaging technique providing enhanced spatial resolution through generation of acoustic signals from light-absorbing molecules in biological systems.[73] In many instances, photoacoustic agents are additionally used to increase imaging contrast due to their specific photophysical properties (high molar extinction coefficient, peak absorption in the NIR window (620–950 nm), high photostability, and efficient conversion of heat energy to produce acoustic waves).[74]\nCNTs might serve as useful photoacoustic contrast agents as they exhibit absorption peaks in the near infrared (NIR) spectral range and possess lower molar extinction coefficients than gold.[74] In particular, the electronic, and thus optical, properties of CNTs can be tuned through changes to the tube structure (for example, diameter and chirality).[74] CNTs functionalized with peptides,[75] dyes,[76] or silica-coated gold nanorods (sGNRs)[77] were used for photoacoustic tumor imaging. Specifically, bare SWCNTs generated transient photoacoustic signals due the rapidly cleared nanotubes, while SWCNTs coupled to the\ncyclic Arg-Gly Asp peptide (denoted SWCNT-RGD) bound to the tumor vasculature, generating a continuous photoacoustic signal from the tumor.[75]\nSWCNTs coupled to an amine-reactive quencher (SWCNTQSY) or indocyanine green (SWCNT-ICG) exhibited approximately two orders of magnitude greater photoacoustic contrast in vivo compared to bare SWCNTs. This observation was ascribed to the increase in the particles’ optical absorption upon conjugation with the dyes[76] Furthermore, the excellent sensitivity was also aided by the affinity of the RGD motif to cancer-specific receptors in tumor-bearing mice. Cui and co-workers enhanced the NIR absorption of MWCNTs through covalent attachment of silica-coated gold nanorods (sGNRs).[77] The sGNR/MWCNT composite was further conjugated with the tumor specific RGD peptide successfully targeting gastric cancer cells in mice achieving strong photoacoustic imaging.[77]\nPhototherapy encompasses light-triggered treatment for tumor ablation and growth inhibition via photodynamic therapy (PDT) and photothermal therapy (PTT). PDT utilizies photosensitized chemical agents responsible for cell toxicity, while in PTT, specific compounds absorb NIR irradiation to generate heat for thermal ablation of cancer cells. CNTs have attracted particular interest because of their extraordinary lightto-heat energy conversion efficiency with a high absorption cross-section of NIR light.[78] PTT applications were reported for bare CNTs[79–81] and CNTs coupled to tumor-specific Abs.[82] SWCNTs were applied as PTT agents together with anticancer drugs, DOX[80] and paclitaxel.[79] CNTs functionalized with noble metals[83] enhanced the photothermal efficacy presumably due to strong plasmonic coupling with the noble metal NPs. Synergistic effects for tumor therapy were reported both in case of PTT and PDT [mediated by the photosensitizer tetrahydroxyphenylchlorin (mTHPC)].[84] In this particular system, the mTHPC was quenched by the MWCNTs (probably due to a charge transfer) and inactivated in the extracellular medium, but once in the cytoplasm after endosomal uptake of the MWCNT complexes it was released and became active following 650 nm light irradiation.[84] Importantly, when CNTs\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (9 of 36)\nsequestered in the lysosomes were irradiated at 808 nm, local heating was generated, inducing cellular damage and apoptosis.\nCNTs were also examined in photoacoustic imaging-guided phototherapy, which generally utilizes materials obtained by complexing photosensitizers with PTT nanomaterials. For example, SWCNTs coupled to indocyanine Green (ICG) and hyaluronic acid nanoparticles (HANP),[85] Chlorin e6 (Ce6)[86] or cyanine 5.5 (Cy5.5)[87] acted as photoacoustic imaging substances for guiding the particles towards the PTT targets. These new biocompatible materials allow complementary imaging modalities and improved tumor accumulation for PDT/PTT treatment compared to the components applied individually. Known magnetic resonance imaging (MRI) contrast agents such as gadolinium (Gd),[88] MnO with polyethylene glycol (PEG)[89] and Mn2+ (chelated with polydopamine–polyethylene glycol (PDA–PEG) poly mer)[90] were also tagged with CNTs for tumor cell imaging."
    }, {
      "heading" : "2.4. CNTs in Tissue Engineering and Regenerative Medicine",
      "text" : "The unique physico-chemical properties of CNTs make them good candidates for use as multi-functional nanomaterials in tissue engineering and regenerative medicine applications.[91] CNTs have been examined as useful platforms for improving the mechanical and electrical properties of artificial tissue scaffolds,[92–94] bone regeneration,[95] augmentation,[96] and cell stimulation actuators.[97] The addition of CNTs significantly improve the conductivity of gelatin methacrylate (GelMA) hydrogels[91,94] and chitosan-hydrogel,[93] improving the spontaneous beating frequencies and physiological functions of encapsulated cardiomyocytes. CNTs were used to increase the mechanical properties\nof gelatin nanofibers and scaffolds for myotubes (multinucleated cells, containing at least three nuclei), and upregulated the activation of mechanotransduction-related genes.[92]\nInteresting applications of CNTs as components of scaffolds mediating cell stimulation have been described. Shin et al. seeded cardiomyocytes onto crosslinked gelatin methacrylate (GelMA) hydrogels reinforced with COOH-MWCNTs.[91] The researchers noticed a 3-fold enhancement in spontaneous beating frequency of the cardiomyocytes in comparison to GelMA-only hydrogels. Specifically, significantly low external voltage was sufficient to induce cell beating due to increased electrical conductivity of the hybrid hydrogels incorporated within the CNTs. These findings were attributed to the presence of aligned sarcomeric structures with tight intercellular junctions. In yet another study, incorporating of SWCNTs in gelatin/chitosan solutions improved the conductivity of hydrogels even at very low concentrations (<100 ppm), thereby aiding signal transmission, promoting functional maturation and synchronous beating of the cardiomyocytes.[95] Specifically, 3D porous chitosan frameworks with different contents of nanocrystalline hydroxyapatite and SWCNTs were fabricated to support the growth of human osteoblasts (bone-forming cells). Two types of SWCNTs were synthesized through arc discharge, with a magnetic field (B-SWCNT) and without (N-SWCNT), and were utilized for improved bone regeneration.[95] The presence of B-SWCNTs in chitosan nanocomposite had a considerable effect on osteoblast attachment and bone regeneration. This might be due to the small aspect ratios of the magnetically synthesized SWCNTs compared to their conventionally synthesized counterparts.\nBio-hybrid tissue actuators (Figure 12) constitute an interesting use of CNTs in tissue engineering.[97] In this work, an\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (10 of 36)\naligned CNT “forest” microelectrode arrays were constructed and employed as scaffolds for cell stimulation. The aligned CNTs were embedded within flexible and biocompatible hydrogels exhibiting anisotropic electrical conductivity. Bio-actuators were engineered by culturing cardiomyocytes on the CNT microelectrode-integrated hydrogel constructs. The resulting cardiac tissue featured homogeneous cell organization with improved cell-to-cell coupling and maturation, and displayed outstanding mechanical integrity with incorporated microelectrode arrays and advanced electrophysiological functions exhibiting strong muscle contraction.[96] This centimeter-scale bio-actuator had an excellent mechanical integrity and was capable of spontaneous actuation behavior.[97] Such devices could be used in bio-robotics and drug screening applications.\nHanein and co-workers used CNT electrodes as conduits for retinal prosthetics.[98,99] Specifically, a semiconductor nanorodCNT (NR-CNT) platform was prepared for wire-free, light induced retina stimulation.[98] CdSe/CdS NRs were covalently attached onto neuro-adhesive, three-dimensional CNT surfaces using polymerized acrylic acid. The interface provided highly efficient photosensitivity and enabled binding between the tissue and the optoelectronic device. The NR-CNT electrodes exhibited good efficiency (i.e., lower threshold for evoking action potentials), durability, flexibility, and demonstrated generation of localized stimulation. In particular, the capacitive charge transfer mechanism and low impedance of CNTs underlined the construction of an effective platform for efficient neuronal light induced stimulation.[98] In another study, the same group used CNT electrodes to stimulate retinal ganglion cells (RGCs) in a mouse model for outer retinal degeneration.[99] In this system, CNTs in the diseased retina enabled gradual remodeling of the inner retina, due to progressive increase of the coupling between RGCs and the CNT electrodes.[99]\nTable 1 summarizes the reports discussed above concerning bio-applications of CNTs and their derivatives."
    }, {
      "heading" : "3. Graphene-Based Materials for Biological Applications",
      "text" : "Graphene is a single layer two-dimensional carbon nanomaterial exhibiting unique physicochemical properties, including high surface area, excellent thermal and electrical conductivity,\nmechanical strength, and ease of functionalization.[100] Graphene, graphene oxide (GO), and reduced graphene oxide (rGO) (Figure 13) are the most common graphene forms and have been used in wide range of applications. Pristine graphene (Figure 13a) is a single-crystalline lattice of sp2-bonded carbon atoms adopting honeycomb-like patterns.[101] Polycrystalline graphene is composed of single-crystalline graphene grains of distinct orientations with a mosaic-like organization restricted by specific grain boundaries generating topological defects, generally termed dislocations.[102] Graphene oxide (GO) (Figure 13b) is a honeycomb lattice with sp2-bonded carbon atoms incorporating sp3 carbon “defects”, displaying oxygencontaining functional groups, such as carboxyl groups exposed on the edges and hydroxyl and epoxy groups on the basal planes.[103] Reduced GO (rGO, Figure 13c) comprises of GO, reduced through chemical or physical methods.[104]\nIn contrast to pristine graphene, which is hydrophobic and thus not soluble in water, GO and rGO can be manipulated and made water-soluble, which is often crucial in biosensing and biological applications. The lateral size of these graphene derivatives modulates the capacity and kinetics of molecular adsorption.[105] Indeed, water solvation properties and varied surface functionalization routes have made GO and rGO promising platforms for biological applications. Furthermore, heterogeneous electron transfer (HET) kinetics of graphene derivatives are directly related to their oxygen content and the density of defect sites, which directly affect their\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (11 of 36)\nfunctionalization efficiencies and thus contribute to their biomedical applicability.[106]\nMost biological applications of graphene and graphene derivatives have been directed at sensing. This is mostly due to the unique physicochemical properties of graphene, particularly high surface area available for binding of target molecules, excellent conductivity providing a sensitive transduction mechanism, relative ease of functionalization, and feasibility of mass production. Below we summarize the main research avenues for graphene utilization."
    }, {
      "heading" : "3.1. Graphene-Based Biosensors",
      "text" : ""
    }, {
      "heading" : "3.1.1. Glucose Biosensing",
      "text" : "Graphene has been successfully employed as a component in glucose sensors, likely the most important biomedical sensing application. Graphene, in general, facilitates direct electrochemical conversion of glucose-oxidase (GOx), the enzyme at the core of numerous glucose sensors.[107] For example, researchers reported sensitive glucose biosensors based on direct electron transfer between GOx and electrode, GOx was either covalently attached or self-assembled upon the surface of electrochemically reduced graphene oxide (abbreviated as ErGO).[108] In those systems, the electron transfer properties of the rGO scaffold were readily tuned through the electrochemical reduction method thus enhancing the direct electron transfer between surface-immobilized GOx and the conductive substrate (GCE), in turn increasing the sensing performance.[108] Superior glucose sensing properties of nitrogen- and sulfur-doped graphene together with GOx was also reported.[109] The improved performance was ascribed to interactions between the N and S heteroatoms. Similar studies have focused on preparation of nanocomposites comprising graphene and conducting polymers. In particular, incorporation of graphene within polymer matrixes exhibiting hydrophilic groups could improve water solubility, enhance the electrical conductivity of graphene, and overall improve the activity of immobilized GOx.[110]\nResearchers utilized Au-graphene nanocomposites as glucose biosensors.[111] Au NPs in such materials provided a suitable microenvironment to immobilize GOx and facilitate efficient electron transfer kinetics at the substrate/enzyme interface. Such nanocomposites were prepared either by covalent modification or by electrodeposition of Au NPs. Graphene\ncomposites comprising other types of nanoparticles have been developed, mostly designed to effectively immobilize GOx in glucose sensors, including MnO2/rGO[112] and ZnO-rGO.[113]\nGraphene-based field effect transistors (FETs) could be useful biosensing platforms as such devices transduce the enzyme recognition events to electrical signals with very high sensitivity.[114,115] Protein-encapsulated graphene based-FET enzymatic biosensors were reported for glucose sensing. For example, You et al. developed a CVD-grown graphene-FET enzymatic glucose biosensor that utilized silk protein as both device substrate and enzyme immobilization matrix. Through modulating drain-source current of the graphene-FET while sweeping the gate voltage, glucose levels could be continuously monitored.[114]\nGraphene-metal hybrids constituted glucose sensors through surface-enhanced Raman scattering (SERS). SERS can enhance the “fingerprints” of target molecules interacting with metal composites’ surfaces through both an electromagnetic mechanism (EM) and chemical mechanism (CM). EM enhancement is usually obtained with electromagnetic “hot spots” exhibiting strongly enhanced local fields,[116] while CM is based on charge transfer and the mixing of molecular orbitals between adsorbed molecules and the SERS substrate.[116] Graphene or GO, in particular, has been shown to enhance SERS via CM due to the high affinity of probe molecules to the GO/graphene layer. For example, Gupta et al. constructed GO-Au/Ag-NPs as a SERSactive substrate for detection of glucose in blood samples.[117] The sensor further contained mercaptophenyl boronic acid (MBA) which contributed to sensitivity and selectivity through complexation between the boronic acid moieties and diol groups of glucose."
    }, {
      "heading" : "3.1.2. DNA Biosensors",
      "text" : "Graphene has been used as a substrate for oligonucleotide immobilization and signal amplification in varied DNA-based biosensors. The considerable surface area of rGO enables high loading of single stranded DNA (ssDNA) probe at the electrode surface, and the high conductivity of graphene accelerates the electron transfer kinetics at the interface.[118–120] Figure 14 illustrates the general fabrication process and sensing mechanism of such sensors. Specifically, electrochemically reduced GO (ErGO) coated conductive substrates are used to anchor the ssDNA probes.[119] Hybridization with the target DNA strain\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (12 of 36)\nwas monitored by measuring the response of electrochemical indicators, such as potassium ferri/ferro cyanide, methylene blue.\nAs an example, Sun and co-workers fabricated an electrochemical DNA biosensor for detection of ssDNA sequence related to transgenic maize, employing ErGO-modified carbon ionic liquid electrode (CILE) as the working electrode, and methylene blue (MB) as the hybridization indicator.[119] In this study, the ssDNA sequence was immobilized on the surface of an ErGO/CILE through electrostatic adsorption; indeed, the presence of ErGO increased the amount of probe ssDNA sequence adsorbed, thereby enhancing the sensitivity of biosensor. In yet another study, the probe ssDNA was covalently attached onto the ErGO, making possible sensitive detection of the target ssDNA of HIV-1 gene using [Fe(CN)6]3−/4− as the hybridization marker.[118] Similarly, Liu et al. coated a GO/graphite fiber hybrid electrode with probe ssDNA through π-stacking interactions between the ssDNA bases and the hexagonal carbon units of GO.[120] In this example, the GO sheets were formed in situ upon the surface of the graphite fibers, in parallel displaying the probe ssDNA.\nIn some instances, signals emanating from graphene-based DNA biosensors have been amplified through co-addition of Au nanoparticles.[121] Au NPs have been used in such systems to amplify hybridization events of ssDNA through increased loading of probe ssDNA on Au NPs. Chen and co-workers have used N-doped graphene-Au nanocomposite for detection of the human multidrug resistance gene using MB as\nan electrochemical indicator.[122] Interestingly, N-doped graphene introduced “defect sites” upon the graphene surface to improve the electrocatalytic properties of the indicator at the interface.\nAn interesting signal amplification strategy was presented using Au nanocluster (NC)/graphene nanohybrids and exonuclease III (Exo III) enzyme-induced cascade.[123] Notably, the graphene-templated Au NC platform was superior to proteintemplated AuNCs in electrochemical performance. Niu and co-workers coupled graphene to perylenetetracarboxylic acid diimide (PDI), a p-type organic semiconductor, also incorporating Au NPs.[124] PDI comprises a five-connected benzene ring (core) which bound graphene through π–π interactions, while the two positive side-chains (arms) acted as a bridge to graft AuNPs. The Au–PDI–graphene nano-hybrid exhibited high sensitivity DNA detection and mismatch recognition, and could detect the genetic trace of HIV-1.[124]\nA “sandwich-type” DNA detection strategy has been developed, based on a capture probe immobilized on the surface of Au NRs attached onto rGO sheets (Figure 15).[125] Specifically, the target DNA strands hybridized with the reporter DNA probe were loaded onto Au NPs, resulting in the formation of capture probe-target DNA-reporter probe “sandwich complex”. Voltammetry was used to interrogate the hybridization event by monitoring the peak current of an electrochemical indicator. Au NRs could offer enhanced sensitivity likely due to their capability in loading hundreds of reporter DNA probes. At the same time, the Au NR–rGO conjugates further increased the\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (13 of 36)\nsensor performance. Other self-assembled capture probes on graphene-gold nanocomposites were used in similar sandwich complex gene detection schemes.[126]\nA novel biosensor for detection of specific DNA insertion sequences of Mycobacterium tuberculosis was developed using rGO–AuNPs as a sensing platform and Au NP–polyaniline (Au–PANI) as a tracer label for signal amplification.[127] In this construct, the rGO-AuNPs matrix was first assembled on a glassy carbon electrode (GCE), providing a large surface area for rapid and efficient electron transfer. The electrochemi cal signal generated by the Au–PANI nanocomposite following DNA hybridization enabled detection of M. tuberculosis with in a low detection limit. A similar PANI-aided rGO-AuNPs nanocomposite sensor for detection of oncogenes was reported.[128]\nZheng et al. fabricated an electrochemical DNA biosensor by exploiting the redox reaction of iron at the core of hemin (an iron-containing porphyrin).[129] The electrochemical transducing interface was formed on AuNPs and a hemin-functionalized rGO-modified GCE. A decrease in the voltammetric response was induced by hybridization between the target DNA and the immobilized probe DNA (pDNA), which consequently blocked the redox reaction of hemin.\nResearchers have also used metal oxide NPs in the fabrication of DNA biosensors. Metal oxide NPs in many instances enhanced oligonucleotide hybridization upon the electrode surface. Specifically, NiO/graphene/ssDNA was shown to effectively detect the pathogenic bacterium Salmonella enteritidis.[130] Similarly, N-graphene/Fe3O4/ssDNA was used for detection of DNA sequences in blood plasma.[131] Similar to other graphene-based sensors discussed above, graphene contributed high conductivity and large surface area, important both for maintaining efficient electron transfer and for providing sites for the deposition of metal oxide nanoparticles. Graphene or rGO-FET biosensors have enabled label-free detection of target ssDNA. In such systems, hybridization induced sensor response through monitoring drain current or drain voltage.[132] Utility and sensitivity of such sensor platforms are\nrelated to high carrier mobility and ambipolar fields in graphene, large surface/detection area, and low intrinsic electrical noises.\nDNA sensing avenues have been demonstrated via GOinduced fluorescence quenching.[133–135] Graphene-induced quenching has been ascribed to three possible mechanisms: Forster resonance energy transfer (FRET), surface energy transfer (SET), and photo-induced electron transfer. In a recent study, ssDNA aptamers served as the recognition elements together with aggregation-induced emission (AIE)-active probes as fluorescent indicators (Figure 16).[134] GO served in this system as a fluorescent quencher, overall yielding a label-free “turn-on” DNA sensor with high selectivity and sensitivity. Initially, the ssDNA aptamer (probe ssDNA, P1) and AIE probe formed a complex, resulting in fluorescence enhancement. Subsequent addition of GO significantly quenched the fluorescence of P1-probe complex, due to fluorescence energy transfer between the ssDNA aptamer and GO that exhibit pronounced binding and close proximity. However, in the presence of the complementary ssDNA target (T1), hybridization of T1 with P1 generated a rigid duplex structure (dsDNA, P1-T1), which weakened the binding between DNA and GO thus lowering the fluorescence quenching induced by GO.[134] GO-induced quenching was also employed as a key parameter in development of a sensitive and rapid method for detection of diseaserelated DNA.[135]"
    }, {
      "heading" : "3.1.3. Graphene-Based Sensors for Other Biomolecular Targets",
      "text" : "Graphene based materials have been used as ethanol sensors.[136–138] In such schemes, both electrochemical and electrochemiluminescence (ECL)-type detection methods have been used. In electrochemical sensing techniques, the electron transfer process of enzymatic reaction (involving alcohol dehydrogenase, denoted as ADH) is monitored and is correlated to ethanol concentration.[139] As an example, a graphene–Au nanorod (Au NR) nanocomposite, synthesized by a simple\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (14 of 36)\nself-assembly process, provided a suitable environment to retain ADH activity and facilitating the electron transfer process in the enzymatic reaction.[137]\nECL has been also used in conjunction with graphene in ethanol sensing. In its essence, ECL is a process of converting electrochemical energy into radiative energy on the surface of an electrode.[140] ECL has been mostly carried out by organic dyes such as tris(2,2′-bipyridine) ruthenium(II) [Ru(bpy)32+].[138] In this context, graphene can provide an effective platform for immobilizing ECL-active molecules.[136] Gao and co-workers fabricated an ECL-based ethanol biosensor based on Ru(bpy)32+ and enzyme (ADH) immobilized upon a rGO/bovine serum albumin (BSA) composite film. In this case, the Ru(bpy)32+ was used to increase the ECL signal while the enzyme was employed to attain selectivity towards the ethanol target. Figure 17 depicts the stages of the ECL sensor construction, in which Ru(bpy)32+, GO, BSA, and ADH were consecutively deposited upon the electrode.[136] In this example, graphene was prepared hydrothermal reduction of GO (at 80 °C for 24 h).\nA similar ECL ethanol biosensor was developed by coimmobilizing the enzyme and Ru(bpy)32+ on poly (3,4-ethylene dioxythiophene) and polystyrene sulfonate functionalized (PEDOT-PSS) graphene nanocomposite film.[141] In this specific example, positively charged Ru(bpy)32+ was immobilized on the electrode surface through affinity to the negatively charged PSS. Moreover, the introduction of PEDOT, a conductive poly mer, contributed to acceleration of the electron transfer.\nGraphene-based materials have been used for detection of organophosphates (OPs).[142–145] Specifically, electrochemical detection of OPs was accomplished by anchoring an enzyme (acetylcholine esterase denoted as AChE) onto Fe3O4/graphene[145] or ZnSe quantum dots/graphene-chitosan.[143] These AChE sensors functioned through inhibition of AChE electrochemical activity upon the reaction OPs, making the signal\ngenerated inversely proportional to OP concentration. In these systems, Fe3O4 or ZnSe quantum dots aided stabilization of the enzyme, while graphene enhanced electron transfer at the sensor interface, thus increasing sensitivity.\nLei and co-workers have reported an esterase-coated chitosan/ AuNPs/graphene for selective detection of OPs in fruit.[142] Similar to AChE discussed above, inhibition of enzyme activity of plant esterase by OPs has been the sensing principle. Graphene facilitated effective electron transfer and electric conductivity in this sensing platform.[142] ECL and photo-electrochemical (PEC) biosensors were reported for OPs based on enzyme/graphene/ quantum dot (QD) composites.[144] Here, rGO was used not only as a substrate to anchor the inorganic QDs and OP-specific enzyme (AChE), but also to significantly amplify the ECL and PEC signals."
    }, {
      "heading" : "3.1.4. Cancer Diagnostics",
      "text" : "Carcinoembryonic antigen (CEA), a tumor marker, has been widely used for early recognition of lung cancer, ovarian carcinoma, breast cancers, and cystadenocarcinoma. Electrochemical immunosensors based on graphene derivatives were reported for the detection of CEA via the monitoring of antigen-antibody complexation. For example, Yu et al. have used rGO to immobilize the antibody directed against CEA together with AuNPs and poly(l-Arginine).[146] The combination ofvAuNPs high surface area, excellent electron transfer capabilities of rGO, contributed to high antibody loading upon the electrode surface and pronounced electrochemical responses.\nSimilar CEA detection schemes, based on anchoring of ultrathin Au-Pt nanowire-decorated thionine/rGO on the glassy carbon electrode (GCE) surface, were reported.[147] Samanman\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (15 of 36)\net al. prepared sensing filaments through a layer by layer assembly, depositing thin films of silver, and then conjugating with a AuNPs-rGO-chitosan nanocomposite functionalized with anti-CEA antibody.[148] Under optimized conditions, the electrochemical response of silver was linearly related to the CEA concentration in the range of 1.0 fg to 1.0 ng·mL−1 with a detection limit of 0.1 fg·mL−1. In another work, Au electrodes were initially altered with rGO-SWCNT-chitosan nanocomposite (Chi-rGO-CNTs) followed by electrodeposition of Au and Pt NPs, and then functionalized with anti-CEA antibody.[149] Kumar et al. reported a new graphene paper electrode built on PEDOT:PSS/rGO as a favorable alternative to expensive conventional electrodes (ITO, gold, or GCE).[150] Sandwich-type graphene-based immunosensors for CEA detection have been also reported. High-affinity antibodies and appropriate labels have been usually employed in such systems.[151] In particular, graphene or rGO sheets have been used both for immobilization of primary antibodies (Ab1) and as tracers for labeling the secondary antibodies (Ab2).[152]\nA CEA sensor in which the graphene surface was altered with magnetic beads (MBs) that were labeled with CEA antibody (Graphene/MBs-Ab1) was reported.[153] Other sandwichtype architectures of graphene-based electrochemical CEA immunosensors were described.[154] In these systems, graphene could enhance the sensitivity through both conjugating recognition elements and increasing the electron transfer kinetics. The prostate specific antigen (PSA) is another important tumor marker, employed in prostate cancer diagnosis and screening. A methodology based upon highly conductive “wrinkled” rGO/ AuNPs, utilized as a sensing element for PSA determination.[155] The 3D immunosensor displayed a linearity in the PSA concentration range of 0.5 to 10 ng·mL−1 with detection limit of 0.59 ng·mL−1. Other graphene-based PSA sensors have been recently demonstrated.\nA multiplex microfluidic chip combined with a GO-based Forster resonance energy transfer (FRET) approach to produce a screening assay for in situ detection of tumor cells was also described.[156] Particularly, a single fluorophore-labeled aptamer (FAM-Sgc8) was selected as a model of the ‘signal-on’ molecular probes due to its high affinity for CCRF-CEM cells. In the free state, the FRET probe of GO/FAM-Sgc8 showed a quenched fluorescence because of π–π stacking interactions, whereas in the presence of target cells, the interaction between FAM-Sgc8 and T-cell acute lymphoblastic leukemia cells (CCRF-CEM) cells was strong enough to discharge FAM-Sgc8 from GO consequently recovering the fluorescence."
    }, {
      "heading" : "3.2. Graphene in Drug and Gene Delivery",
      "text" : "The biocompatible material, graphene/rGO/GO has been widely used as vehicle for the delivery of drugs/gens to the target site from locate of administration, because of its precise surface area of graphene and ease of polymeric alteration and, conjugation approaches.[157] For example, GO-sodium alginate (SA) conjugate was used as a carrier for the anticancer drug, DOX.[158] In this study, DOX was loaded onto the surface of GO-SA hybrid via pi-pi stacking and hydrogenbonding interactions. High drug loading onto the carrier matrix\nand good release profile were achieved. In another study, GO modified with surfactants (hydroxyethyl cellulose-neutral and hydroxyethyl cellulose-anionic surfactant) via noncovalent attachment) was shown to improve the stability and dispersion of a GO-DOX composite under physiological conditions.[159]\nDOX delivery has been also achieved by decorating rGO with antibodies or receptors. For example, an anti-human epidermal receptor 2 (anti-HER2) antibody-conjugated poly L-lysine functionalized rGO (anti-HER2-rGO-PLL) nanocarrierfor efficiently delivered DOX to cancer cells over-expressing HER2.[160] The combination of specific antibody and conjugation of PLL, a cell-penetrating peptide, lead to an excellent cell uptake. In a similar approach, folic acid (FA)-rGO (FA-rGO) loaded with DOX showed specific targeting to MDA-MB 231 cancer cells (expressing the FA receptor) and exhibited excellent drugrelease efficiency.[161] In other studies, GO functionalized with lactobionic acid (LA), another cancer cell specific ligand, displayed targeting for cancer cells over expressing the ASGPR receptors.[162]\nChen and co-workers prepared a Fe3O4–PEG–GO nanocomposite, for both magnetic imaging and drug delivery.[163] The hybrid exhibited good physiological stability and did not adversely affect cell viability. Moreover, high loading of an anti-cancer drug (DOX) was achieved. Notably, the nanocomposite exhibited significantly improved T2-weighted magnetic resonance imaging (MRI) contrast compared to bare Fe3O4 NPs, ascribed to formation of Fe3O4 NP aggregates upon the GO sheets. In a similar approach, GO grafted with dendrimers capped with amino groups and functionalized with gadolinium diethylene triaminepentaacetate (Gd-DTPA) and an antibody targeted to prostate stem cell antigen (PSCA) was employed for targeting and MR imaging of cancer cells overexpressing PSCA.[164] Yet in another study, pH-responsive supramolecular polymeric shell around a mesoporous silica-coated magnetic GO (Fe3O4@GO@mSiO2) was used for DOX delivery to cancerous tissue in a controlled manner. Fe3O4 endowed magnetic field sensitivity of the GO composite, designed to enable delivery DOX to target sites by application of external magnetic fields.[165]\nFluorescent manganese-doped zinc sulfide (ZnS/Mn) nanocrystals were covalently attached to GO-PEG for drug delivery and cell labeling.[166] Specifically, DOX was physically adsorbed onto the GO surface, while PEG enhanced the solubility and biocompatibility of the material. The fluorescent ZnS/Mn nanocrystals used label the HeLa cells.[166] Bare GO and hydroxyl-ethylated GO were used as delivery agents for the anticancer drug methotrexate (MTX).[167–169] MTX was loaded either through covalent bonding (via amide linkage)[167] or by noncovalent bonding,[168] and pH-based release mechanisms were demonstrated. Noncovalent bonding (via π−π stacking and hydrophobic interactions) between the drug cargo and GO was also reported.[169]\nGraphene-based materials have been useful conduits for gene delivery.[170] In a representative study, GO-branched polyethylenimine (denoted as BPEI) fabricated through conjugation of low-molecular weight BPEI with GO improved DNA binding and condensation and transfection efficiency. The BPEI–GO hybrid was used as a delivery vehicle for siRNA. In another study, GO nanocarriers were conjugated by covalent linkage\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (16 of 36)\nor electrostatic interactions with varied cationic polymers and employed for delivery of plasmid DNA (pDNA).[171]"
    }, {
      "heading" : "3.3. Phototherapy Applications of Graphene Derivatives",
      "text" : "Graphene materials (GO, rGO, and GO composites) have shown promise as platforms for photothermal therapy (PTT), due to strong interactions with low-frequency photons at infrared frequencies. Graphene derivatives exhibit plasmonic effects upon NIR irradiation generating heat through plasmonic photothermal conversion.[172] GO systems implemented for PTT have included rGO nanomesh (rGONM) functionalized with polyethylene glycol (PEG), arginine–glycine–aspartic acid (RGD) recognition peptide, and cyanine 7 (Cy7).[173] In another study, peptide-conjugated polydopamine-modified rGO (pDA/rGO) was constructed, promoting a “bystander effect” (in which individual damaged cells transfer toxic signals to adjacent cells), and used as a conduit for cancer treatment using NIR-activated PTT.[174]\nLim and co-workers have used a gold nanoshells and nanorods coated with rGO that produce an enhanced PTT effect upon NIR irradiation.[175] Another group reports water soluble Cu2O nanocrystal–rGO as cancer therapeutic agent.[176] The narrow direct band gap of Cu2O (2.0–2.2 eV) made this material useful for killing cancerous cells under visible light irradiation. Functionalized rGO, gold nanostars (GNS), and doxorubicin (DOX) (denoted as rGO-GNS@DOX) have been developed for combined photothermal treatment and chemotherapy of metastatic breast cancer.[177] In this example, the NIR absorbance of rGO was enhanced by introduction of in the composite, which will certainly improve the PPT. Many more graphene based reports also available for PTT.\nCombined photo acoustic (PA) therapy and PTT were employed by indocyanine green-loaded polydopamine-rGO (ICG-PDA-rGO) for cancer theranostics (e.g., therapy and diagnostics).[178] The nanocomposite induced local hyperthermia thereby killing breast cancer cells under NIR irradiation. In vivo GO-enabled PA imaging in tumor bearing mice was applied demonstrated significantly stronger PA signal than its controls (Figure 18). In another study, a theranostic probe Cy5.5-peptide-PEG-GO/Au was prepared through chemical conjugation, in which GO/Au facilitated strong NIR absorbance and higher photoconversion efficiency.[179] This probe possessed high tumor accumulation and significantly enhanced fluorescence and photo acoustic signals for in vivo cell imaging.[179] Recently, size-tunable rGO-coated gold superparticles (e.g., Au nanocrystals forming colloidal assemblies) (rGO-GSPs) were used for both photoacoustic imaging and enhanced photothermal therapy.[180]"
    }, {
      "heading" : "3.4. Graphene Biomaterials in Tissue Engineering",
      "text" : "Graphene, GO, rGO, and their composites further containing metals or polymers) offer exciting opportunities to stimulate cells in artificial scaffolds, primarily due to their tunable surface properties. In particular, the physicochemical properties of graphene-based materials intimately influence surface interactions of individual cells and cell populations.[181] Several studies explored applications of graphene or GO as substances for bone[182–184] and neural[185] tissue engineering. In a representative study, graphene constituted a platform for non-covalent display of osteogenic inducers, which accelerate stem cell growth.[182] The oxygen functionalities of GO facilitated differentiation the stem cells through intermolecular\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (17 of 36)\ninteractions (π–π interactions, electrostatic attraction, or hydrogen bonding with cell proteins).[182]\nOther interesting graphene nanostructures such as self-supporting graphene hydrogel (SGH) films were employed for rat bone regeneration, primarily due to the corrugated and porous surface of the material which exerted mechanical stimulation on the cytoskeleton.[183] In another study, graphene nanogrids prepared via unzipping of multiwalled carbon nanotubes were used as two dimensional selective templates for differentiation of human mesenchymal stem cells (hMSCs). This was presumed to occur through the induced mechanical stress upon the nanogrids.[184] In other approaches, polymer-functionalized GO could effectively induce stem cell growth, due to the synergetic effect of graphene and the macromolecules.[185] In these studies, biopolymers or synthetic polymers provided surface charge and different chemical moieties such as amine, carboxyl, hydroxyl, and sulfate on the graphene surface, which were important for cell growth and differentiation studies (via effective intermolecular interactions).\nIn an interesting application, GO-nanofiber hybrid scaffolds selectively guided differentiation of neural stem cells into mature oligodendrocytes, which are the myelinating cells of the central nervous system.[186] Figure 19 depicts a GO-nanofiber hybrid scaffold composed of polycaprolactone nanofibers coated with GO and seeded with neural stem cells (NSCs). The NSCs cultured on the GO-nanofiber hybrid scaffolds exhibited enhanced stem cell differentiation into oligodendrocyte lineage cells. In this system, the synergetic effect provided by the three dimensional features of the nanofibers and the surface properties of GO were highly beneficial for protein adsorption and cell adhesion.[186] Other examples described growth of functional neural circuits upon graphene matrixes and improved neural performance and electrical signaling in the\nnetwork through the interactions between graphene and neural stem cells.[187] Table 2 summarizes the publications discussed above pertaining to biological applications of graphene-based nanostructures."
    }, {
      "heading" : "4. Graphene Quantum Dots and Carbon Dots",
      "text" : "Graphene quantum dots (denoted GQDs, Figure 20a) and carbon dots (C-dots, Figure 20b) constitute a fairly novel class of zero-dimensional carbon nanostructures.[7,188] These carbon nanoparticles generally exhibit tunable photoluminescence (PL), low photo-bleaching, biocompatibility, and low cytotoxicity, making them viable alternatives to traditional fluorescent dyes, fluorescent proteins, and semiconductor quantum dots.[189] In particular, these features have made GQDs and C-dots useful and promising conduits for biological sensing and bio-imaging applications. In addition, the significant surface area and abundant edge sites contribute to efficient electron transfer\nAdv. Healthcare Mater. 2017, 1700574\nTable 2. Graphene-based nanomaterials for biological and biomedical applications.\nGraphene-based materials Ref.\n1 Graphene-based biosensors\nGlucose biosensing [108–117]\nDNA biosensors [119–135]\nGraphene-based sensors for other biomolecular targets [136–145]\nCancer diagnostics [146–156]\n2 Graphene in drug and gene delivery [158–171]\n3 Phototherapy applications of graphene derivatives [173–180]\n4 Graphene biomaterials in tissue engineering [182–187]\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (18 of 36)\nprocesses upon GQD and C-dot surfaces, enabling their use in electrochemical sensing and electrocatalytic applications."
    }, {
      "heading" : "4.1. GQD- and C-Dot-Based Biosensors",
      "text" : ""
    }, {
      "heading" : "4.1.1. Glucose Biosensing",
      "text" : "Due to the biomedical importance of glucose sensing, many applications have been developed for using GQDs and C-dots as platforms for glucose detection. Qui et al. prepared borondoped GQDs (BGQDs) through hydrothermal synthesis, and utilized these nanoparticles for selective detection of glucose through an aggregation-induced photoluminescence (PL) increase mechanism.[190] Specifically, rigid BGQDs−glucose aggregates were formed through binding between two\ninduced mechanism.\nPL quenching was the transduction mechanism in another study depicting C-dots pre-\npared through the carbonization of citric acid and APBA as a passivating agent.[192] In comparison, PL recovery of C-dots passivated with 4-cyanophenylboronic acid (CPBA) was used for monitoring blood glucose.[193] Initially, CPBA passivation of the C-dots resulted in PL quenching via charge transfer from C-dots to CPBA; however, addition of glucose gave rise to modulation of electron distribution in the aromatic moiety of CPBA leading to increase of fluorescence emission.\nC-dots were also functionalized with boronic acid for detection of glucose in blood serum samples (Figure 22).[194] In that study, the C-dots were prepared through hydrothermal carbonization of phenylboronic acid (Figure 22A). PL quenching occurred upon addition of glucose, due to the covalent binding between the cis-diols of glucose and boronic acid of the C-dot surface leading to intercalation among the particles\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (19 of 36)\n(Figure 22B). The covalent network gave rise to quenching of the C-dots’ fluorescence as apparent in Figure 22C.\nUsing similar concepts, hemin-functionalized GQDs[195] and metalloporphyrin-functionalized GQDs[196] coupled to glucose oxidase (GOx) facilitated “on-off” glucose detection in serum samples. In both systems, hydrogen peroxide released following the reaction between GOx and glucose, disrupted the passivated GQDs’ surface, resulting in fluorescence quenching (Figure 23). Specifically, in the hemin-GQDs catalyzed H2O2 reaction, free radicals (hydroxyl and carbon-centered radicals) were generated and induces further oxidation of surface passivated units of GQDs or destroy the passivation of GQDs, leading to significant fluorescence quenching of GQDs (≈86%). In the latter study, the metalloporphyrin induced PL quenching of the GQDs, as its absorbance band overlapped with the emission band of the GQDs; the “on” PL state was re-introduced upon reaction between H2O2 and metalloporphyrin to dipyrroles and monopyrroles.[196]\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (20 of 36)\nIn an interesting strategy, Zhou and co-workers immobilized C-dots onto glucose-imprinted polymer microgels and demonstrated continuous selective detection of glucose in physiological pH.[197] The glucose-imprinted microgels could reversibly quench the fluorescence signals of the embedded C-dots in response to glucose. In another investigation, GQD nanofibers, prepared through electrospinning of water-soluble GQDs with polyvinyl alcohol (PVA), was utilized for glucose and H2O2 detection.[198] The sensing modality was based upon quenching of the GQDs’ upon addition of glucose or H2O2."
    }, {
      "heading" : "4.1.2. Biomarker Detection",
      "text" : "Several types of immunosensors based on C-dots and GQDs have been developed for disease diagnosis. Miao and co-workers\nprepared COOH-functionalized C-dots through carbonization of tomato juice, and coupled them to aptamers recognizing the carcinoembryonic antigen (CEA), a cancer biomarker (Figure 24).[199] In the experiment, the CEA-aptamers were attached onto the C-dots through pi-pi stacking, giving rise to fluorescence quenching. Binding of the CEA to the C-dot-displayed aptamers caused their detachment from the C-dots and concomitant recovery of the C-dots’ fluorescence (Figure 24B). This scheme produced continuous, sensitive, and recyclable CEA assay.\nA ratiometric nanoprobe was prepared by chelation of Tb3+ ions with carboxyl and amine groups upon C-dots’ surface, employed for detection of an anthrax biomarker, dipicolinic acid (DPA).[200] In this study, prior to DPA addition, the emission spectrum was dominated by the band of C-dots; however\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (21 of 36)\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (22 of 36)\nas C-dots and DPA excite with the same wavelength, the emission intensity of the Tb3+ ions was enhanced though energy transfer from DPA, in the presence of the marker. The fluorescence peaks of C-dots in aqueous solution were unchanged as a reference, while the Tb3+ ions exhibited enhanced fluorescence emission upon binding of DPA, enabling ratiometric DPA detection. A similar detection concept was reported in which Eu3+-functionalized GQDs, prepared through chelation of Eu3+ ions onto carboxyl and amine groups upon the GQDs’ surface, were used for DPA detection.[201] A rapid and sensitive immunoassay was developed for detection of ovarian cancer biomarkers through chemiluminescence resonance energy transfer (CRET). In the experiment, signal transduction was based upon CRET from a chemiluminescent reagent (luminol) to the GQDs.[202] GQDs offers various advantages, as the energy acceptor avoids the photo-bleaching problem, which is usually associated with organic dyes, and enables efficient energy transfer.\nElectrochemiluminescence (ECL) sensors utilizing GQDs or C-dots have been developed for detection of cancer biomarkers. While GQDs and C-dots generally generate weak ECL signals, their coupling to metal or semiconductor NPs enhances their ECL signal through enrichment of C-dots concentration. In a representative example, C-dots/CdTe were synthesized, designed to serve as ECL labels for the sensitive detection of squamous cell carcinoma antigen (SCCA), a cancer biomarker, through electrochemiluminescent resonance energy transfer (ECRET) (Figure 25).[203] Specifically, C-dots/CdTes were immobilized on a carrier antibody (C-dots/CdTe@Ab2) for capture of the SCCA antigen in solution. The SCCA was “sandwiched” between Ab2 and another antibody, immobilized on Fe2O3modified electrode (Fe2O3 NPs/Ab1). Electrochemically excited species (C-dots/CdTes) emit luminescence upon the recognition SCCA by both the Abs, as shown in Figure 25.[203] In the presented work, two Abs have been used to enable the sensitive detection of biomarkers, one that is Ab2, used to pre-concentrate the antigen and other one that is Ab1, immobilized on the electrode surface for transduction of antigen-Ab2. In addition, both Abs were immobilized on NPs to enhance the sensitivity through enrichment of Abs surface concentration (intern increase the antigen-antibody interaction) and C-dots (which leading to enhance the ECL signal).\nIn another example, like C-dots, GQDs have been also employed as ECL labels for cancer biomarker detection through the above explained mechanism.[204] In the experiment, GQDs assembled PtPd NPs, used as ECL label, to enhance the ECL biosensing performance and Au-Ag NPs, used to modify the electrode substrate to increase the electrochemical reaction.[204] Specifically, the recognition layer constitutes PtPd NPs, employed to enrich the concentration of GQDs to enhance the ECL signal, and Au-Ag NPs which enhanced the electrochemical reaction."
    }, {
      "heading" : "4.1.3. Detection of Metal Ions and pH in Biological Systems",
      "text" : "C-dots constitute both efficient electron donors and electron acceptors, enabling detection of metal ions and pH through electrostatic attraction. In particular, functional groups upon C-dots’ surface (formed either by carbonizing the carbon precursor\ncontaining specified functional groups, or by chemical coupling of desired functional groups after C-dot synthesis) have distinctive affinities to different target metal ions and pH, which results in modulation of the C-dots’ fluorescence. Numerous reports of such ion and pH sensors have appeared in the literature. As an example, a fluorescent sensor was demonstrated for intracellular detection Cu2+ by C-dots synthesized from citric acid and polyethylenimine (PEI) as carbon precursors via a onestep microwave method at low temperature.[205] In the experiment, the amine groups on the C-dots’ surface retained their Cu2+ recognition capabilities, quenching the C-dots’ fluorescence following addition of small amounts of Cu2+ ions. Such quenching can be ascribed to electrostatic interactions between Cu2+ and negatively charged residues upon the C-dots’ surface, leading to chelation and aggregation of the dots. Cu2+-mediated aggregation and quenching of C-dots’ fluorescence was used as a vehicle for copper ion sensing in rat brain’s striatum.[206]\nC-dots derived from various starting materials were used to detect different ions in physiological solutions and cells, including Hg2+, Ag2+, Cr3+, Fe3+, K+, Cl-, and H+.[205,207] The ion detection mechanisms are similar, involving quenching of the C-dots’ PL via electron or energy transfer mechanisms. C-dots have been also employed as pH sensors in living cells and tissues. Tian and co-workers synthesized aminomethylphenylterpyridine (AE-TPY) C-dots to probe pH changes in physiological conditions.[208] The sensing mechanism relies upon PL quenching through the interaction of protons with the surface groups of C-dots (Figure 26). In particular, pH sensing in that system exploited two-photon fluorescence (TPF) induced by near infrared (NIR) excitation. Importantly, this C-dot sensor was successfully applied in living cells and tumor tissues.\nA multicolor-emitting block copolymer-integrated graphene quantum dots (bcp-GQDs), prepared through\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (23 of 36)\ngrafting of blue-emitting thermally responsive block copoly mer onto green-emitting GQDs, was employed for simultaneous sensing of temperature, pH, and metal ions.[209] In the experiment, sensing was accomplished through monitoring Förster resonance energy transfer (FRET) between the bcp (emitting in blue) and GQDs (exhibiting green emission), which was dependent upon the different types of stimuli. Numerous C-dots-based sensors have been reported for detection of diverse biomolecular targets. A C-dot-based ratiometric sensor has been developed for detection of riboflavin.[210] other studies reported the fluorescence turn-on or turn-off C-dots based sensor for the detection of cysteine,[211] dopamine,[212] ascorbic acid,[213] bisphenol,[214] glutathione,[215] guanine,[216] hydroquinone,[217] and chelostral.[218]\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (24 of 36)\nAdv. Healthcare Mater. 2017, 1700574"
    }, {
      "heading" : "4.1.4. Biosensing of Oligonucleotides",
      "text" : "Interactions of specifically designed C-dots with oligonucleotides which result in fluorescence modulation made possible use of C-dots as conduits for DNA sensing. Ultrasensitive detection of DNA sequences related to HIV was accomplished through FRET between C-dots and AuNPs (serving as quenchers) (Figure 27).[219] In the experiment, the PL of C-dots functionalized with a probe ssDNA was quenched upon addition of AuNPs through FRET. Recovery of the PL was achieved upon exposure of C-dots-probe ssDNA/AuNps to target ssDNA, affected by dissociation of C-dots-duplex DNA and AuNPs, due to the strong electrostatic repulsion between the negatively charged duplex DNA and AuNPs.\nC-dots, prepared though microwave treatment of banana peels, were used as reducing agents and stabilizers of a Pd/Au/C-dot nanocomposite. This material was used for electrochemical detection of colitoxin DNA in human serum.[220] Specifically, the probe-DNA was immobilized on the Pd-Au@C-dots through covalent bonding between COOH groups upon the C-dots and the probe DNA which was NH3+-terminated. Methylene blue (MB) was used as an electrochemi cal indicator for monitoring the hybridization between the probe DNA and target DNA."
    }, {
      "heading" : "4.1.5. Bacterial detection",
      "text" : "Bacterial cells have been shown to modulate the fluorescence properties of C-dots, opening the way for innovative bacterial sensing strategies. Nandi et al. synthesized amphiphilic C-dots functionalized with hydrocarbon chains for the detection of bacterial cells\nsuch as E. coli; S. typhimurium; P. aeruginosa; and B. cereus.[221] In the experiment, both the intensity and shift of the C-dots’ fluorescence emission were significantly modulated upon insertion of the C-dots into the bacterial cells’ membranes, making possible bacterial detection through fluorescence spectroscopy or microscopy (Figure 28). Distinct binding profiles of the amphiphilic C-dots have been observed with each bacterial strain, accounting for the different cell surface properties (i.e., different lipid compositions, molecular organization, and macroscopic structures).\nIn another study, bacterial detection was achieved by employing a hydrogel embedding C-dots (Figure 29).[222] Initially, the C-dots were distributed within the hydrogel, stabilized through a network of hyfrogen bonds. In this environment, the fluorescence of the C-dot was high since no aggregation occurred. However, in the presence of bacteria, bacterially secreted esterases induced cleavage of ester bonds within the hydrogel scaffold, resulting in fluidization of the hydrogel. This, in turn, gave rise to aggregation of the embedded C-dots and consequent quenching of their fluorescence.\nIn another approach, magnetic carbon dots (Mag-C-dots), prepared through combining magnetic Fe3O4 NPs and aminefunctionalized C-dots, were used for sensing the pathogenic bacteria Staphylococcus aureus and Escherichia coli in urine samples.[223] The fluorescence intensity of the Mag-C-dots increased, presumably through more pronounced binding of the bacterial cells to the nanoparticles."
    }, {
      "heading" : "4.2. Carbon Dots in Drug Delivery",
      "text" : "C-dots offer useful pathways for both drug- and gene-delivery. Figure 30 depicts hollow C-dots, prepared via a carbonization\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (25 of 36)\nAdv. Healthcare Mater. 2017, 1700574\nprocess with bovine serum albumin as the carbon source, serving as hosts for drug cargo.[224] Of particular importance is that the C-dots retained their luminescence after loading of drug/gene, thus serving both as a vehicle for drug delivery, as well as for tracking the particles via fluorescence microscopy.[224]\nC-dots have been investigated as conduits for delivery of genes by surface passivating with positively charged polymeric materials, thereby delivering genetic material through electrostatic attraction. As an example, Liu et al. successfully prepared a C-dot gene-delivery platform through carbonization of polyethylenimine (PEI), a positively charged polymer. (Figure 31).[225] The outer cationic moieties mediated plasmid DNA transfection, and the entrapped C-dots’ fluorescence also serves as a vehicle for bio-imaging.\nC-dots constituted scaffolds for intracellular delivery of small interfering RNA (siRNA, or “silencing RNA”, which is capable of deactivating expression of target genes).[226] The siRNA transport system was prepared through functionalization of the C-dots with PEI, which had a dual role in the system–a carrier for docking the siRNA, and enabling transport of the C-dot complexes across the plasma membrane and cell uptake. In another study, direct synthesis of C-dots using oligonucleotides as the carbon source was explored, using the particles as a vehicle for cell imaging (using the C-dots’ fluorescence) and drug delivery.[227] The C-dots, which were derived from genomic DNA (isolated from Escherichia coli), displayed varied surface groups, thus facilitating drug transport through electrostatic interactions and were readily internalized by different types of cells. In addition, similar to the example above, the C-dots’ fluorescence enabled cell imaging.\nIn an interesting multifunctional system, C-dots served as both target delivery platform, anticancer agents, and imaging constituents.[228] Specifically, the C-dots were functionalized with a mitochondria-recognition moiety (triphenylphosphonium, TPP), and a photo-responsive nitric oxide (NO) releasing moiety. NO works as a potent cytotoxic agent due to its inhibition of mitochondrial respiration. The C-dots thus bound and damaged intracellular mitochondria via light induced NO release, initiating apoptosis of the cancer cells (Figure 32). In addition, the C-dots’ fluorescence allowed assessment of the extent of C-dot buildup and localization within the mitochondria."
    }, {
      "heading" : "4.3. Bio-Imaging Applications of C-Dots",
      "text" : "The fluorescence properties of C-dots, particularly their excitation-dependent emissions, make these nanoparticle potentially useful for biological imaging applications.\nIn a recent study, amphiphilic C-dots were employed for multicolor cell imaging.[229] In the experiment, C-dots which were surface-functionalized with long hydrocarbon chains, were incorporated within lipid vesicles that were subsequently cellinternalized through endocytic pathways. Figure 33 depicts confocal fluorescence microscopy images which confirmed successful internalization of the C-dots into the cells, and their homogeneous distribution within cellular environments such as the cytosol and nucleoli.\nIn another study, C-dots were prepared from three phenylenediamine precursors and employed for imaging epithelial cells (Figure 34).[230] The distinct colors of the C-dots were related to the three phenylenediamine isomers (ortho, meta, and para), resulting in difference in their particle size and nitrogen content. Cell labeling was accomplished through incubation of MCF-7 cells with each C-dot species; the live cells were imaged with a confocal microscope under a single 405 nm laser excitation.\nFRET was exploited for monitoring drug delivery into cells (Figure 35).[231] In that study, surface functional groups of the C-dots served as energy donor while the loaded drug compound doxorubicin (DOX) acted as energy acceptor. These C-dots were\nFigure 32. Multifunctional mitochondria-targeting C-dots. A) Outline of the C-dot’s activity. C-dots exhibiting a mitochondria-recognition element (triphenylphosphonium, TPP) and photoresponsive NO-release moiety were prepared for targeting and damaging the mitochondria, leading to apoptosis of the cancer cells. B) Representation and surface moiety structures of the C-dots (S-nitrosthiol on the left, and TPP on the right). C) photo responsive release mechanism of NO from the surface passivated moiety. Reproduced with permission.[228] Copyright 2014, The Royal Society of Chemistry.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (26 of 36)\nAdv. Healthcare Mater. 2017, 1700574\nemployed for both fluorescence imaging of the cellular targets, and drug distribution through FRET. Specifically, imaging was carried out by uv excitation of the C-dots, energy transfer via FRET to the DOX molecules which consequently exhibited fluorescence emission at 498 nm, allowing for visualization of drug distribution. Importantly, time-dependent imaging studies revealed the decay of the DOX fluorescence as a consequence of their release within the cells.[231]\nCell targeting and imaging through the attachment of recognition elements to C-dots was also carried out. A recent study demonstrated cancer cell imaging by displaying folic acid on C-dots’ surface (Figure 36).[232] Folic acid is a convenient target agent for cancer cells in which the surface folate receptors are over-expressed. In that study, folic acid units were covalently bonded to the C-dots, which were then utilized for the selective tagging of cancer cells, e.g., HeLa cells. In yet another study, C-dots were hydrothermally synthesized from folic acid as carbon precursor, consequently enabling selective imaging of cancer cells.[233]\nC-dots have been also used for in vivo imaging. Tumor imaging was demonstrated by using C-dots that were prepared through the carbonization of a mixture containing D-glucose and L-aspartic acid (Figure 37).[234] Particularly, these C-dots displayed more pronounced uptake in cancerous glioma cells and tumors, likely due to the specific binding of the aspartic acid/ glucose elements of the C-dots and integrins (cell adhesion proteins) which are overexpressed in glioma cells (Figure 37 Top). In the in vivo experiment, the C-dots preferentially collected in the brains of mice with glioma tumors, demonstrating that the carbon nanoparticles were not only specific but could also be effectively transported\nacross the physiologically important blood-brain barrier (BBB) (Figure 37 bottom).\nOther reports presented imaging systems consisting of C-dots conjugated with other reporting modalities. C-dots/ gadolinium ion conjugates (C-dot-Gd nanoparticles), prepared through the pyrolysis of a positively charged ligand and subsequently coupled to a negatively charged Gd3+containing complex, can be employed for both fluorescence\nFigure 33. Amphiphilic C-dots employed in cell imaging. Bright-field image (A) and confocal fluorescence microscopy images of epithelial Chinese hamster ovary (CHO) cells incubated with amphiphilic C-dots. The images were recorded at excitation of 405 nm (B); 488 nm (C) and 561 nm (D). Scale bar is 10 µm. Reproduced with permission.[229] Copyright 2014, The Royal Society of Chemistry.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (27 of 36)\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (28 of 36)\nAdv. Healthcare Mater. 2017, 1700574\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (29 of 36)\nAdv. Healthcare Mater. 2017, 1700574\nand magnetic resonance imaging (Figure 38).[235] Gadolinium is a common contrast agent in magnetic resonance imaging (MRI), reducing the T1 relaxation of water protons and consequently enhancing their magnetic resonance signal."
    }, {
      "heading" : "4.4. C-Dots in Photodynamic Therapy",
      "text" : "C-dots have been utilized in photodynamic therapy (PDT). In PDT, tumor cells are destroyed upon exposure to oxygen radicals, released upon light irradiation of a “photosensitizer” (PS). For example, Chen et al. reported a PDT strategy based upon two-photon absorbance by C-dots (Figure 39).[236]\nThe PDT system consisted of C-dots covalently bound to a porphyrin derivative (TMPyP), employed as the PS. A fundamental restriction of the use of standalone TMPyP as a PS therapeutic compound is that it absorbs light only in the visible spectrum. The designed C-dots platform were able to absorb light in the NIR (700 nm) region which, crucially, penetrates through tissues. Upon irradiation by NIR light, the C-dots emitted light which wavelength coincided with the excitation of TMPyP; the resultant energy transfer activated the TMPyP release of triplet oxygen radicals and subsequent cell killing.\nIn another study, GQDs could serve as PDT agents generating singlet oxygen radicals (reactive oxygen species, ROS) likely due to the transfer of the excitation energy of the C-dots\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (30 of 36)\nAdv. Healthcare Mater. 2017, 1700574\nto an “excited triplet state” (Figure 40).[237] As described in Figure 40, energy required for generating reactive oxygen species (singlet or triplet oxygen) could be produced through two transitions – the excited singlet state to the triplet state, and the triplet state to the ground state of the GQDs. This multistate sensitization mechanism differs significantly from the single transition photosensitization mechanism in conventional PDT agents and may enable more efficient PDT activity through the production of high concentrations of reactive oxygen species by the GQDs. Table 3 outlines publications discussed above focusing on biological and biomedical applications of carbon dots."
    }, {
      "heading" : "5. Clinical and Practical Aspects",
      "text" : "Although carbon nanomaterials represent an important niche in the field of innovative materials for next-generation nanomedicines, no carbon nanomaterial-based therapeutic products have won regulatory approval yet. Clinical trials of CNTs as components of external medical devices for cancer diagnostics were initiated in 2011[238] and as breath nanosensors for gastric cancer.[239] The apparent disparity between the significant activity and progress in carbon nanomaterial research and scant advances in the realm of practical biomedical applications might certainly be a detrimental issue for further advances in the field.\nA prominent issue that is naturally pivotal for potential future therapeutic applications of carbon is toxicity. Potential adverse effects of CNTs, graphene, graphene oxide, and their derivatives have been discussed in several reviews.[240] Specifically, there is a need to identify safe morphologies and delivery routes of therapeutic carbon nanomaterials. Non-specific adsorption of carbon nanomaterials to biological molecules in vivo is\nTable 3. Biological applications of GQDs and C-dots.\nGraphene quantum dots and carbon dots Ref.\n1 GQD- and C-dot-based biosensors\nGlucose biosensing [190–198]\nBiomarker detection [199–204]\nDetection of metal ions and pH in biological systems [205–218]\nBiosensing of oligonucleotides [219,220]\nBacterial detection [221–223]\n2 Carbon dots in drug delivery [224–228]\n3 Bio-imaging applications of C-dots [229–235]\n4 Photodynamic therapy [236,237]\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (31 of 36)\nAdv. Healthcare Mater. 2017, 1700574\nconsidered another important factor affecting their toxicity profile. Graphene, for example, nonspecifically binds to proteins in vivo by π-stacking interactions and electrostatic interactions.[241] GO displaying reactive COOH and OH groups can be conjugated with various functional proteins, leading to irreversible denaturation (or activation) of proteins and potential long-term toxicity.[242] Graphene was also shown to nonspecifically bind to various proteins, even when it is functionalized with targeting residues such as aptamers.[133] In addition, nonspecific binding of chemotherapeutic agents delivered by carbon nanomaterials leads to undesired side effects on normal tissues and insufficient dosages for killing target cancer cells.[243]\nOther safety issues need to be researched before wider acceptance of carbon nanomaterials for therapeutic applications. Among the central questions are aspects pertaining to circulation and long-term fate (clearance rate) in blood, interactions of graphene with human blood cells and proteins. Other physiological issues include the effects of carbon nanomaterials on ion channels and cell signaling pathways. Further, investigating interactions of carbon nanoparticles with pulmonary surfactant proteins and their overall pulmonary responses are critical due to inhalation of these materials. In addition, the effects of carbon nanomaterials on the immune system, reproductive systems, and neural networks have yet to be thoroughly investigated.[244]\nTechnologies for minimizing potentially adverse environmental effects of carbon nanomaterials have been pursued. Biodegradation technologies may be able to meet this need. For example, recent studies have reported that peroxidase enzyme-based processes could lead to oxidative degradation of carbon nanoparticles in biological systems.[245] On a cellular level, a degradation process has been demonstrated for carbon nanotubes[246] and graphene.[247] Very few studies are currently available on the capacity of phagocytic cells or specific tissues to induce carbon nanomaterial degradation following in vivo administration in animal models.[248]\nBacteria and other microorganisms have been proposed as conduits for degradation of carbon nanomaterials in the environment either through oxidation or through reduction reactions. As an example, Liu et al. successfully isolated a naphthalene degrading bacterium from the contaminated soil in a graphite mine, that could degrade graphitic materials including GO, graphite, and reduced GO (rGO).[249] Interestingly, the bacterium had different degrading effects on different carbon materials. Specific enzymes have been also employed for carbon nanoparticle removal. Myeloperoxidase has been shown to oxidize SWCNTs.[250] It has been also shown that binding of SWCNTs to human serum albumin through electrostatic interactions between the SWCNTs’ carboxyl groups and arginine residues of the protein, and π–π stacking interactions of SWCNTs with the tyrosine residues significantly enhanced SWCNT biodegradation.[251]"
    }, {
      "heading" : "6. Conclusions",
      "text" : "Carbon nanomaterials, specifically carbon nanotubes (CNTs), graphene, and carbon quantum dots, have been used as powerful platforms for diverse biological and biomedical\napplications. These nanomaterials have been employed as biosensors, drug and gene delivery vehicles, bio-imaging agents, therapeutic materials, and tissue engineering scaffolds. The contributions of these carbon nanomaterials to such diverse applications have been aided by the unique physico-chemical properties of these nanostructures, their biocompatibility, and the varied routes of surface derivatization. While technical and conceptual challenges still need to be addressed, carbon nanomaterials will likely continue to be used in numerous and expanding biological applications."
    }, {
      "heading" : "Acknowledgements",
      "text" : "We are grateful for the Ministry of Science and Technology, China-Israel Grant Program for financial support.\nConflict of Interest The authors declare no conflict of interest.\nKeywords biomedical applications, carbon nanotubes, carbon quantum dots, graphene\nReceived: May 4, 2017 Revised: June 12, 2017\nPublished online:\n[1] H. W. Kroto, J. R. Heath, S. C. O’Brien, R. F. Curl, R. E. Smalley, Nature 1985, 318, 162. [2] S. Iijima, Nature 1991, 354, 56. [3] K. S. Novoselov, A. K. Geim, S. V. Morozov, D. Jiang, Y. Zhang,\nS. V. Dubonos, I. V. Grigorieva, A. A. Firsov, Science 2004, 306, 666. [4] a) D. Pan, J. Zhang, Z. Li, M. Wu, Adv. Mater. 2010, 22, 734;\nb) Y.-P. Sun, B. Zhou, Y. Lin, W. Wang, K. S. Fernando, P. Pathak, M. J. Meziani, B. A. Harruff, X. Wang, H. Wang, J. Am. Chem. Soc. 2006, 128, 7756. [5] a) G. Hong, S. Diao, A. L. Antaris, H. Dai, Chem. Rev. 2015, 115, 10816; b) R. Alshehri, A. M. Ilyas, A. Hasan, A. Arnaout, F. Ahmed, A. Memic, J. Med. Chem. 2016, 59, 8149; c) F. Lu, L. Gu, M. J. Meziani, X. Wang, P. G. Luo, L. M. Veca, L. Cao, Y. P. Sun, Adv. Mater. 2009, 21, 139. [6] a) V. Georgakilas, J. N. Tiwari, K. C. Kemp, J. A. Perrnan, A. B. Bourlinos, K. S. Kim, R. Zboril, Chem. Rev., 2016, 116, 5464; b) S. Pattnaik, K. Swain, Z. Lin, J. Mater. Chem. B 2016, 4, 7813; c) J. Lee, J. Kim, S. Kim, D.-H. Min, Adv. Drug Deliv. Revs. 2016, 105, 275. [7] X. T. Zheng, A. Ananthanarayanan, K. Q. Luo, P. Chen, Small 2015, 11, 1620. [8] a) S. N. Baker, G. A. Baker, Angew. Chem. Int. Ed. 2010, 49, 6726; b) L. Li, G. Wu, G. Yang, J. Peng, J. Zhao, J.-J. Zhu, Nanoscale 2013, 5, 4015. [9] Z. Liu, S. M. Tabakman, Z. Chen, H. Dai, Nat. Protocols 2009, 4, 1372. [10] a) H.-C. Wu, X. Chang, L. Liu, F. Zhao, Y. Zhao, J. Mater. Chem. 2010, 20, 1036; b) V. C. Moore, M. S. Strano, E. H. Haroz, R. H. Hauge, R. E. Smalley, J. Schmidt, Y. Talmon, Nano Lett.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (32 of 36)\nAdv. Healthcare Mater. 2017, 1700574\n2003, 3, 1379; c) A. B. Bourlinos, D. Gournis, D. Petridis, T. Szabó, A. Szeri, I. Dékány, Langmuir 2003, 19, 6050; d) L. Q. Xu, W. J. Yang, K.-G. Neoh, E.-T. Kang, G. D. Fu, Macromolecules 2010, 43, 8336; e) T. A. Pham, N. A. Kumar, Y. T. Jeong, Synth. Met. 2010, 160, 2028. [11] C. B. Jacobs, M. J. Peairs, B. J. Venton, Anal. Chim. Acta 2010, 662, 105. [12] N. Yang, X. Chen, T. Ren, P. Zhang, D. Yang, Sens. Actuat. B: Chemical 2015, 207, 690. [13] a) S. Vaddiraju, I. Tomazos, D. J. Burgess, F. C. Jain, F. Papadimitrakopoulos, Biosens. Bioelectron. 2010, 25, 1553; b) J. Wang, Electroanalysis 2001, 13, 983. [14] F. Patolsky, Y. Weizmann, I. Willner, Angew. Chem. Int. Ed. 2004, 43, 2113. [15] J. H. Kim, S.-A. Jun, Y. Kwon, S. Ha, B.-I. Sang, J. Kim, Bioelectrochem. 2015, 101, 114. [16] M. Vesali-Naseh, A. A. Khodadadi, Y. Mortazavi, A. A. Moosavi-Movahedi, K. Ostrikov, RSC Adv. 2016, 6, 31807. [17] a) P. N. Manikandan, H. Imran, V. Dharuman, Anal. Methods 2016, 8, 2691; b) S. Palanisamy, S. Cheemalapati, S.-M. Chen, Int. J. Electrochem. Sci. 2012, 7, 8394. [18] B.-Y. Wu, S.-H. Hou, F. Yin, Z.-X. Zhao, Y.-Y. Wang, X.-S. Wang, Q. Chen, Biosens. Bioelectron. 2007, 22, 2854. [19] Y. L. Yao, K. K. Shiu, Electroanalysis 2008, 20, 1542. [20] H. Heli, M. Hajjizadeh, A. Jabbari, A. Moosavi-Movahedi, Biosens.\nBioelectron. 2009, 24, 2328. [21] A. H. Crisp, M. G. Gelder, S. Rix, H. I. Meltzer, O. J. Rowlands,\nBrit. J. Psychiatry 2000, 177, 4. [22] a) D. Du, M. Wang, J. Cai, Y. Qin, A. Zhang, Sens. Actuat. B: Chem-\nical 2010, 143, 524; b) N. Jha, S. Ramaprabhu, Nanoscale 2010, 2, 806. [23] J. Ding, H. Zhang, F. Jia, W. Qin, D. Du, Sens. Actuat. B: Chemical 2014, 199, 284. [24] M. Kesik, F. E. Kanik, J. Turan, M. Kolb, S. Timur, M. Bahadir, L. Toppare, Sens. Actuat. B: Chemical 2014, 205, 39. [25] B. Dalkıran, P. E. Erden, E. Kılıç, Anal. Bioanal. Chem. 2016, 408, 4329. [26] a) A. Azadbakht, M. Roushani, A. R. Abbasi, S. Menati, Z. Derikvand, Mater. Sci. Eng.: C 2016, 68, 585; b) S. F. Rahman, K. Min, S.-H. Park, J.-H. Park, J. C. Yoo, D.-H. Park, Korean J. Chem. Eng. 2016, 33, 3442. [27] Ş. Alpat, K. Özdemir, S. Kılınç Alpat, J. Sens. 2016, 2016, 5653975. [28] S. Mukdasai, V. Langsi, M. Pravda, S. Srijaranai, J. D. Glennon,\nSens. Actuat. B: Chemical 2016, 236, 126. [29] B. Batra, C. Pundir, Biosens. Bioelectron. 2013, 47, 496. [30] a) S. Lata, B. Batra, P. Kumar, C. Pundir, Anal. Biochem. 2013,\n437, 1; b) S. Lata, B. Batra, N. Singala, C. Pundir, Sens. Actuat. B: Chemical 2013, 188, 1080; c) Q. Wang, X. Lin, J. Xu, C. Xuan, S. Zhu, Y. Fu, J. Electrochem. Soc. 2016, 163, B373; d) Q. Xia, Y. Huang, X. Lin, S. Zhu, Y. Fu, Biochem. Eng. J. 2016, 113, 1. [31] a) Y. Liu, Y. Liu, H. Feng, Y. Wu, L. Joshi, X. Zeng, J. Li, Biosens. Bioelectron. 2012, 35, 63; b) H. Zarei, H. Ghourchian, K. Eskandari, M. Zeinali, Anal. Biochem. 2012, 421, 446. [32] Y.-T. Chang, J.-H. Huang, M.-C. Tu, P. Chang, T.-R. Yew, Biosens. Bioelectron. 2013, 41, 898. [33] a) M. Zheng, A. Jagota, E. D. Semke, B. A. Diner, R. S. Mclean, S. R. Lustig, R. E. Richardson, N. G. Tassi, Nat. Mater. 2003, 2, 338; b) M. Zheng, E. D. Semke, J. Am. Chem. Soc. 2007, 129, 6084. [34] V. Karachevtsev, A. Y. Glamazda, V. Leontiev, O. Lytvyn, U. Dettlaff-Weglikowska, Chem. Phys. Lett. 2007, 435, 104. [35] Z. Liang, R. Lao, J. Wang, Y. Liu, L. Wang, Q. Huang, S. Song, G. Li, C. Fan, Int. J. Mol. Sci. 2007, 8, 705.\n[36] C. Hu, Y. Zhang, G. Bao, Y. Zhang, M. Liu, Z. L. Wang, J. Phys. Chem. B 2005, 109, 20072. [37] Z. Wu, Z. Zhen, J.-H. Jiang, G.-L. Shen, R.-Q. Yu, J. Am. Chem. Soc. 2009, 131, 12325. [38] A. Benvidi, M. D. Tezerjani, S. Jahanbani, M. M. Ardakani, S. M. Moshtaghioun, Talanta 2016, 147, 621. [39] M. Chen, C. Hou, D. Huo, M. Yang, H. Fa, Appl. Surf. Sci. 2016, 364, 703. [40] J. Li, E.-C. Lee, Sens. Actuat. B: Chemical 2017, 239, 652. [41] Y. Huang, M. Shi, L. Zhao, S. Zhao, K. Hu, Z.-F. Chen, J. Chen,\nH. Liang, Biosens. Bioelectron. 2014, 54, 285. [42] a) Y.-E. Choi, J.-W. Kwak, J. W. Park, Sensors 2010, 10, 428;\nb) M. Ferrari, Nat. Revs. Cancer 2005, 5, 161; c) N. G. Portney, M. Ozkan, Anal. Bioanal. Chem. 2006, 384, 620. [43] a) M. R. Kierny, T. D. Cunningham, B. K. Kay, Nano Revs. 2012, 3, 17240; b) M. Ramanathan, M. Patil, R. Epur, Y. Yun, V. Shanov, M. Schulz, W. R. Heineman, M. K. Datta, P. N. Kumta, Biosens. Bioelectron. 2016, 77, 580. [44] D. P. Matta, S. Tripathy, S. R. K. Vanjari, C. S. Sharma, S. G. Singh, Biomed. Microdevices 2016, 18, 111. [45] F. Yuan, Y. Deng, W. Zhou, M. Zhang, Z. Li, Nano Res. 2016, 9, 1701. [46] S. Kumar, R. Rani, N. Dilbaghi, K. Tankeshwar, K.-H. Kim, Chem. Soc. Rev. 2017, 46, 158. [47] Z. Wang, Z. Dai, Nanoscale 2015, 7, 6420. [48] R. Malhotra, V. Patel, J. P. Vaqué, J. S. Gutkind, J. F. Rusling, Anal.\nChem. 2010, 82, 3118. [49] Y. Wan, W. Deng, Y. Su, X. Zhu, C. Peng, H. Hu, H. Peng, S. Song,\nC. Fan, Biosens. Bioelectron. 2011, 30, 93. [50] E. Arkan, R. Saber, Z. Karimi, M. Shamsipur, Anal. Chim. Acta\n2015, 874, 66. [51] M. B. Lerner, J. D’souza, T. Pazina, J. Dailey, B. R. Goldsmith,\nM. K. Robinson, A. C. Johnson, ACS Nano 2012, 6, 5143. [52] M. Abdolahad, M. Janmaleki, M. Taghinejad, H. Taghnejad, F. Salehi, S. Mohajerzadeh, Nanoscale 2013, 5, 3421. [53] M. Abdolahad, M. Taghinejad, H. Taghinejad, M. Janmaleki, S. Mohajerzadeh, Lab Chip 2012, 12, 1183. [54] a) C. Chen, X.-X. Xie, Q. Zhou, F.-Y. Zhang, Q.-L. Wang, Y.-Q. Liu, Y. Zou, Q. Tao, X.-M. Ji, S.-Q. Yu, Nanotechnol. 2012, 23, 045104; b) H. Huang, Q. Yuan, J. Shah, R. Misra, Adv. Drug Deliv. Revs. 2011, 63, 1332. [55] Z. Ji, G. Lin, Q. Lu, L. Meng, X. Shen, L. Dong, C. Fu, X. Zhang, J. Colloid Interface Sci. 2012, 365, 143. [56] C. Chen, L. Hou, H. Zhang, L. Zhu, H. Zhang, C. Zhang, J. Shi, L. Wang, X. Jia, Z. Zhang, J. Drug Target 2013, 21, 809. [57] M. Das, R. P. Singh, S. R. Datir, S. Jain, Mol. Pharm. 2013, 10, 3404. [58] a) G. Cirillo, S. Hampel, U. G. Spizzirri, O. I. Parisi, N. Picci, F. Iemma, BioMed Res. Int. 2014, 2014; b) M. Mohseni, K. Gilani, Z. Bahrami, N. Bolourchian, S. A. Mortazavi, Iranian J. Pharm. Res.: IJPR 2015, 14, 359; c) A. Servant, C. Bussy, K. Al-Jamal, K. Kostarelos, J. Mater. Chem. B 2013, 1, 4593. [59] B. Kang, J. Li, S. Chang, M. Dai, C. Ren, Y. Dai, D. Chen, Small 2012, 8, 777. [60] a) A. Giri, T. Bhunia, L. Goswami, A. B. Panda, A. Bandyopadhyay, RSC Adv. 2015, 5, 41736; b) A. Giri, T. Bhunia, S. R. Mishra, L. Goswami, A. B. Panda, A. Bandyopadhyay, RSC Adv. 2014, 4, 13546; c) A. Giri, T. Bhunia, A. Pal, L. Goswami, A. Bandyopadhyay, Eur. Polym. J. 2016, 74, 13. [61] T. Bhunia, A. Giri, T. Nasim, D. Chattopadhyay, A. Bandyopadhyay, Carbon 2013, 52, 305. [62] B. Mandal, D. Das, A. P. Rameshbabu, S. Dhara, S. Pal, RSC Adv. 2016, 6, 19605.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (33 of 36)\nAdv. Healthcare Mater. 2017, 1700574\n[63] A. Pistone, D. Iannazzo, S. Ansari, C. Milone, M. Salamò, S. Galvagno, S. Cirmi, M. Navarra, Int. J. Pharm. 2016, 515, 30. [64] A. Servant, L. Methven, R. P. Williams, K. Kostarelos, Adv. Healthcare Mater. 2013, 2, 806. [65] J. Wang, Z. Lu, M. G. Wientjes, J. L.-S. Au, AAPS J. 2010, 12, 492. [66] C. Geyik, S. Evran, S. Timur, A. Telefoncu, Biotechnol. Progr. 2014,\n30, 224. [67] S. Taghavi, A. H. Nia, K. Abnous, M. Ramezani, Int. J. Pharm.\n2017, 516, 301. [68] a) Y.-P. Huang, I.-J. Lin, C.-C. Chen, Y.-C. Hsu, C.-C. Chang,\nM.-J. Lee, Nanoscale Res. Lett. 2013, 8, 267; b) C. Spinato, D. Giust, I. A. Vacchi, C. Ménard-Moyon, K. Kostarelos, A. Bianco, J. Mater. Chem. B 2016, 4, 431. [69] T. Anderson, R. Hu, C. Yang, H. S. Yoon, K.-T. Yong, Biomaterials Sci. 2014, 2, 1244. [70] H. Li, X. Fan, X. Chen, ACS Appl. Mater. Interfaces 2016, 8, 4500. [71] T. Ohta, Y. Hashida, F. Yamashita, M. Hashida, J. Pharm. Sci. 2016,\n105, 2815. [72] a) J. Chen, S. Chen, X. Zhao, L. V. Kuznetsova, S. S. Wong,\nI. Ojima, J. Am. Chem. Soc. 2008, 130, 16778; b) Y. Hashida, T. Umeyama, J. Mihara, H. Imahori, M. Tsujimoto, S. Isoda, M. Takano, M. Hashida, J. Pharm. Sci. 2012, 101, 3398; c) S. Zhou, Y. Hashida, S. Kawakami, J. Mihara, T. Umeyama, H. Imahori, T. Murakami, F. Yamashita, M. Hashida, Int. J. Pharm. 2014, 471, 214. [73] A. G. Bell, Am. J. Sci. 1880, 305. [74] J. Weber, P. C. Beard, S. E. Bohndiek, Nat. Methods 2016, 13, 639. [75] A. De La Zerda, C. Zavaleta, S. Keren, S. Vaithilingam, S. Bodapati,\nZ. Liu, J. Levi, B. R. Smith, T.-J. Ma, O. Oralkan, Nat. Nanotechnol. 2008, 3, 557. [76] A. de Zerda, S. Bodapati, R. Teed, S. Y. May, S. M. Tabakman, Z. Liu, B. T. Khuri-Yakub, X. Chen, H. Dai, S. S. Gambhir, ACS Nano 2012, 6, 4694. [77] C. Wang, C. Bao, S. Liang, H. Fu, K. Wang, M. Deng, Q. Liao, D. Cui, Nanoscale Res. Lett. 2014, 9, 1. [78] a) M. J. O’connell, S. M. Bachilo, C. B. Huffman, V. C. Moore, M. S. Strano, E. H. Haroz, K. L. Rialon, P. J. Boul, W. H. Noon, C. Kittrell, Science 2002, 297, 593; b) J. Zhang, Z. Qiao, P. Yang, J. Pan, L. Wang, H. Wang, Chin. J. Chem. 2015, 33, 35. [79] P. Jeyamohan, T. Hasumura, Y. Nagaoka, Y. Yoshida, T. Maekawa, D. S. Kumar, Int. J. Nanomedicine 2013, 8, 2653. [80] H. K. Moon, S. H. Lee, H. C. Choi, ACS Nano 2009, 3, 3707. [81] L. Zhang, P. Rong, M. Chen, S. Gao, L. Zhu, Nanoscale 2015, 7,\n16204. [82] a) H.-T. Chou, T.-P. Wang, C.-Y. Lee, N.-H. Tai, H.-Y. Chang, Mater.\nSci. Eng.: C 2013, 33, 989; b) S. Han, T. Kwon, J. E. Um, S. Haam, W. J. Kim, Adv. Healthcare Mater. 2016, 5, 1147; c) L. Wang, J. Shi, H. Zhang, H. Li, Y. Gao, Z. Wang, H. Wang, L. Li, C. Zhang, C. Chen, Biomaterials 2013, 34, 262. [83] a) J. Song, F. Wang, X. Yang, B. Ning, M. G. Harp, S. H. Culp, S. Hu, P. Huang, L. Nie, J. Chen, J. Am. Chem. Soc. 2016, 138, 7005; b) D. Wang, C. Hou, L. Meng, J. Long, J. Jing, D. Dang, Z. Fei, P. J. Dyson, J. Mater. Chem. B 2017; c) X. Wang, C. Wang, L. Cheng, S.-T. Lee, Z. Liu, J. Am. Chem. Soc. 2012, 134, 7414. [84] I. Marangon, C. Ménard-Moyon, A. K. Silva, A. Bianco, N. Luciani, F. Gazeau, Carbon 2016, 97, 110. [85] G. Wang, F. Zhang, R. Tian, L. Zhang, G. Fu, L. Yang, L. Zhu, ACS Appl. Mater. Interfaces 2016, 8, 5608. [86] L. Xie, G. Wang, H. Zhou, F. Zhang, Z. Guo, C. Liu, X. Zhang, L. Zhu, Biomaterials 2016, 103, 219. [87] X. Liang, W. Shang, C. Chi, C. Zeng, K. Wang, C. Fang, Q. Chen, H. Liu, Y. Fan, J. Tian, Cancer Lett. 2016, 383, 243. [88] a) L. Hou, X. Yang, J. Ren, Y. Wang, H. Zhang, Q. Feng, Y. Shi, X. Shan, Y. Yuan, Z. Zhang, Int. J. Nanomed. 2016, 11, 607;\nb) S. Wang, Q. Lin, J. Chen, H. Gao, D. Fu, S. Shen, Carbon 2017, 112, 53. [89] S. Wang, Q. Zhang, P. Yang, X. Yu, L.-Y. Huang, S. Shen, S. Cai, ACS Appl. Mater. Interfaces 2015, 8, 3736. [90] H. Zhao, Y. Chao, J. Liu, J. Huang, J. Pan, W. Guo, J. Wu, M. Sheng, K. Yang, J. Wang, Theranostics 2016, 6, 1833. [91] S. R. Shin, S. M. Jung, M. Zalabany, K. Kim, P. Zorlutuna, S. bok Kim, M. Nikkhah, M. Khabiry, M. Azize, J. Kong, ACS Nano 2013, 7, 2369. [92] S. Ostrovidov, X. Shi, L. Zhang, X. Liang, S. B. Kim, T. Fujie, M. Ramalingam, M. Chen, K. Nakajima, F. Al-Hazmi, Biomaterials 2014, 35, 6268. [93] S. Pok, F. Vitale, S. L. Eichmann, O. M. Benavides, M. Pasquali, J. G. Jacot, ACS Nano 2014, 8, 9822. [94] S. R. Shin, H. Bae, J. M. Cha, J. Y. Mun, Y.-C. Chen, H. Tekin, H. Shin, S. Farshchi, M. R. Dokmeci, S. Tang, ACS Nano 2012, 6, 362. [95] O. Im, J. Li, M. Wang, L. G. Zhang, M. Keidar, Int. J. Nanomed. 2012, 7, 2087. [96] E. Hirata, C. Ménard-Moyon, E. Venturelli, H. Takita, F. Watari, A. Bianco, A. Yokoyama, Nanotechnol. 2013, 24, 435101. [97] S. R. Shin, C. Shin, A. Memic, S. Shadmehr, M. Miscuglio, H. Y. Jung, S. M. Jung, H. Bae, A. Khademhosseini, X. S. Tang, Adv. Funct. Mater. 2015, 25, 4486. [98] L. Bareket, N. Waiskopf, D. Rand, G. Lubin, M. David-Pur, J. Ben-Dov, S. Roy, C. Eleftheriou, E. Sernagor, O. Cheshnovsky, Nano Lett. 2014, 14, 6685. [99] C. G. Eleftheriou, J. B. Zimmermann, H. D. Kjeldsen, M. David-Pur, Y. Hanein, E. Sernagor, Biomaterials 2017, 112, 108. [100] a) P. Avouris, C. Dimitrakopoulos, Mater. Today 2012, 15, 86; b) B. H. Nguyen, V. H. Nguyen, Adv. Natural Sci.: Nanosci. Nanotechnol. 2016, 7, 023002; c) Y. Yang, A. M. Asiri, Z. Tang, D. Du, Y. Lin, Mater. Today 2013, 16, 365. [101] L. Rodríguez-Pérez, M. Á. Herranz, N. Martín, Chem. Commun. 2013, 49, 3721. [102] O. V. Yazyev, Y. P. Chen, Nat. Nanotechnol. 2014, 9, 755. [103] D. R. Dreyer, S. Park, C. W. Bielawski, R. S. Ruoff, Chem. Soc. Rev.\n2010, 39, 228. [104] B. J. Hong, Z. An, O. C. Compton, S. T. Nguyen, Small 2012, 8,\n2469. [105] J. Lee, Y. Yim, S. Kim, M.-H. Choi, B.-S. Choi, Y. Lee, D.-H. Min,\nCarbon 2016, 97, 92. [106] a) M. F. El-Kady, R. B. Kaner, Nat. Commun. 2013, 4, 1475;\nb) E. Morales-Narváez, L. Baptista-Pires, A. Zamora-Gálvez, A. Merkoçi, Adv. Mater. 2017, 29, 1604905. [107] a) Y. Shao, J. Wang, H. Wu, J. Liu, I. A. Aksay, Y. Lin, Electroanalysis 2010, 22, 1027; b) M. Zhou, Y. Zhai, S. Dong, Anal. Chem. 2009, 81, 5603. [108] a) B. Liang, L. Fang, G. Yang, Y. Hu, X. Guo, X. Ye, Biosens. Bioelectron. 2013, 43, 131; b) B. Unnikrishnan, S. Palanisamy, S.-M. Chen, Biosens. Bioelectron. 2013, 39, 70; c) K. Vijayaraj, S. W. Hong, S.-H. Jin, S.-C. Chang, D.-S. Park, Anal. Methods 2016, 8, 6974. [109] G. Chen, Y. Liu, Y. Liu, Y. Tian, X. Zhang, J. Electroanal. Chem. 2015, 738, 100. [110] a) M. M. Barsan, M. David, M. Florescu, L. T’ugulea, C. M. Brett, Bioelectrochemistry 2014, 99, 46; b) M. David, M. M. Barsan, M. Florescu, C. Brett, Electroanalysis 2015, 27, 2139; c) S. Li, J.-X. Xiong, C.-X. Chen, F.-Q. Chu, Y. Kong, L.-H. Deng, Mater. Technology 2017, 32, 1; d) C. Ruan, W. Shi, H. Jiang, Y. Sun, X. Liu, X. Zhang, Z. Sun, L. Dai, D. Ge, Sens. Actuat. B: Chemical 2013, 177, 826. [111] a) S.-J. Li, T.-W. Chen, N. Xia, Y.-L. Hou, J.-J. Du, L. Liu, J. Solid State Electrochem. 2013, 17, 2487; b) P. Rafighi, M. Tavahodi, B. Haghighi, Sens. Actuat. B: Chemical 2016, 232, 454.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (34 of 36)\nAdv. Healthcare Mater. 2017, 1700574\n[112] a) Y. Liu, X. Zhang, D. He, F. Ma, Q. Fu, Y. Hu, RSC Adv. 2016, 6, 18654; b) A. E. Vilian, V. Mani, S.-M. Chen, B. Dinesh, S.-T. Huang, Indust. Eng. Chem. Res. 2014, 53, 15582. [113] Y. Zhao, W. Li, L. Pan, D. Zhai, Y. Wang, L. Li, W. Cheng, W. Yin, X. Wang, J.-B. Xu, Sci. Rep. 2016, 6. [114] X. You, J. J. Pak, Sens. Actuat. B: Chemical 2014, 202, 1357. [115] J. W. Park, C. Lee, J. Jang, Sens. Actuat. B: Chemical 2015, 208, 532. [116] X. Li, W. C. Choy, X. Ren, D. Zhang, H. Lu, Adv. Funct. Mater. 2014,\n24, 3114. [117] V. K. Gupta, N. Atar, M. L. Yola, M. Eryılmaz, H. Torul, U. Tamer,\nİ. H. Boyacı, Z. Üstündaǧ, J. Colloid Interface Sci. 2013, 406, 231. [118] Q. Gong, H. Yang, Y. Dong, W. Zhang, Anal. Methods 2015, 7,\n2554. [119] W. Sun, Y. Lu, Y. Wu, Y. Zhang, P. Wang, Y. Chen, G. Li, Sens.\nActuat. B: Chemical 2014, 202, 160. [120] J. Zhang, A. Li, X. Yu, W. Guo, Z. Zhao, J. Qiu, X. Mou,\nJ. P. Claverie, H. Liu, Adv. Mater. Interfaces 2015, 2. [121] a) S. Hajihosseini, N. Nasirizadeh, M. S. Hejazi, P. Yaghmaei,\nMater. Sci. Eng.: C 2016, 61, 506; b) S. M. Khoshfetrat, M. A. Mehrgardi, RSC Adv. 2015, 5, 29285; c) H.-z. Pan, H.-w. Yu, N. Wang, Z. Zhang, G.-c. Wan, H. Liu, X. Guan, D. Chang, J. Biotechnol. 2015, 214, 133. [122] M. Chen, C. Hou, D. Huo, J. Bao, H. Fa, C. Shen, Biosens. Bioelectron. 2016, 85, 684. [123] W. Wang, T. Bao, X. Zeng, H. Xiong, W. Wen, X. Zhang, S. Wang, Biosens. Bioelectron. 2017, 91, 183. [124] W. Zhang, F. Li, Y. Hu, S. Gan, D. Han, Q. Zhang, L. Niu, J. Mater. Chem. B 2014, 2, 3142. [125] A. Shi, J. Wang, X. Han, X. Fang, Y. Zhang, Sens. Actuat. B: Chemical 2014, 200, 206. [126] A.-L. Liu, G.-X. Zhong, J.-Y. Chen, S.-H. Weng, H.-N. Huang, W. Chen, L.-Q. Lin, Y. Lei, F.-H. Fu, Z.-l. Sun, Anal. Chim. Acta 2013, 767, 50. [127] C. Liu, D. Jiang, G. Xiang, L. Liu, F. Liu, X. Pu, Analyst 2014, 139, 5460. [128] L. Wang, E. Hua, M. Liang, C. Ma, Z. Liu, S. Sheng, M. Liu, G. Xie, W. Feng, Biosens. Bioelectron. 2014, 51, 201. [129] Y. Ye, J. Gao, H. Zhuang, H. Zheng, H. Sun, Y. Ye, X. Xu, X. Cao, Microchimica Acta 2017, 184, 245. [130] W. Sun, X. Wang, Y. Lu, S. Gong, X. Qi, B. Lei, Z. Sun, G. Li, Mater. Sci. Eng.: C 2015, 49, 34. [131] M. Chen, C. Hou, D. Huo, H. Fa, Y. Zhao, C. Shen, Sens. Actuat. B: Chemical 2017, 239, 421. [132] a) B. Cai, S. Wang, L. Huang, Y. Ning, Z. Zhang, G.-J. Zhang, ACS Nano 2014, 8, 2632; b) J. Ping, R. Vishnubhotla, A. Vrudhula, A. C. Johnson, ACS Nano 2016, 10, 8700; c) X. Zhang, Y. Zhang, Q. Liao, Y. Song, S. Ma, Small 2013, 9, 4045; d) C. Zheng, L. Huang, H. Zhang, Z. Sun, Z. Zhang, G.-J. Zhang, ACS Appl. Mater. Interfaces 2015, 7, 16953. [133] C. H. Lu, H. H. Yang, C. L. Zhu, X. Chen, G. N. Chen, Angew. Chem. 2009, 121, 4879. [134] H. Wang, K. Ma, B. Xu, W. Tian, Small 2016, 12, 6613. [135] J. Zhang, M. Tao, Y. Jin, Analyst 2014, 139, 3455. [136] W. Gao, Y. Chen, J. Xi, S. Lin, Y. Chen, Y. Lin, Z. Chen, Biosens.\nBioelectron. 2013, 41, 776. [137] L. Li, H. Lu, L. Deng, Talanta 2013, 113, 1. [138] W. Miao, Chem. Rev. 2008, 108, 2506. [139] Y. Kitagawa, K. Kitabatake, I. Kubo, E. Tamiya, I. Karube, Anal.\nChim. Acta 1989, 218, 61. [140] S. Swanson, S. Jacobs, D. Mytych, C. Shah, S. Indelicato,\nR. Bordens, Dev. Biol. Standard. 1998, 97, 135. [141] Y. Gao, J. Li, X. Yang, Q. Xiang, K. Wang, Electroanalysis 2014, 26,\n382. [142] J. Bao, C. Hou, M. Chen, J. Li, D. Huo, M. Yang, X. Luo, Y. Lei,\nJ. Agric. Food. Chem. 2015, 63, 10319.\n[143] J. Dong, H. Zhao, F. Qiao, P. Liu, X. Wang, S. Ai, Anal. Methods 2013, 5, 2866. [144] a) H. Liang, D. Song, J. Gong, Biosens. Bioelectron. 2014, 53, 363; b) Q. Liu, J. Cai, J. Huan, X. Dong, C. Wang, B. Qiu, K. Wang, Analyst 2014, 139, 1121. [145] H. Wang, G. Zhao, D. Chen, Z. Wang, G. Liu, Int. J. Electrochem. Sci. 2016, 11, 10906. [146] S. Yu, X. Cao, M. Yu, Microchem. J. 2012, 103, 125. [147] a) J. Han, J. Ma, Z. Ma, Biosens. Bioelectron. 2013, 47, 243;\nb) W. Lu, J. Ge, L. Tao, X. Cao, J. Dong, W. Qian, Electrochim. Acta 2014, 130, 335. [148] S. Samanman, A. Numnuam, W. Limbut, P. Kanatharana, P. Thavarungkul, Anal. Chim. Acta 2015, 853, 521. [149] X. Jiang, Y. Chai, R. Yuan, Y. Cao, Y. Chen, H. Wang, X. Gan, Anal. Chim. Acta 2013, 783, 49. [150] S. Kumar, S. Kumar, S. Srivastava, B. K. Yadav, S. H. Lee, J. G. Sharma, D. C. Doval, B. D. Malhotra, Biosens. Bioelectron. 2015, 73, 114. [151] X. Pei, B. Zhang, J. Tang, B. Liu, W. Lai, D. Tang, Anal. Chim. Acta 2013, 758, 1. [152] a) Y. Cheng, R. Yuan, Y. Chai, H. Niu, Y. Cao, H. Liu, L. Bai, Y. Yuan, Anal. Chim. Acta 2012, 745, 137; b) J. Huang, J. Tian, Y. Zhao, S. Zhao, Sens. Actuat. B: Chemical 2015, 206, 570. [153] B. Jin, P. Wang, H. Mao, B. Hu, H. Zhang, Z. Cheng, Z. Wu, X. Bian, C. Jia, F. Jing, Biosens. Bioelectron. 2014, 55, 464. [154] a) Y. Cao, R. Yuan, Y. Chai, H. Liu, Y. Liao, Y. Zhuo, Talanta 2013, 113, 106; b) Y. Zhang, M. Su, L. Ge, S. Ge, J. Yu, X. Song, Carbon 2013, 57, 22; c) X. Jiang, Y. Chai, H. Wang, R. Yuan, Biosens. Bioelectron. 2014, 54, 20; d) J. Yan, M. Yan, L. Ge, S. Ge, J. Yu, Sens. Actuat. B: Chemical 2014, 193, 247. [155] H. D. Jang, S. K. Kim, H. Chang, J.-W. Choi, Biosens. Bioelectron. 2015, 63, 546. [156] L. Cao, L. Cheng, Z. Zhang, Y. Wang, X. Zhang, H. Chen, B. Liu, S. Zhang, J. Kong, Lab Chip 2012, 12, 4864. [157] A. Gulzar, P. Yang, F. He, J. Xu, D. Yang, L. Xu, M. O. Jan, Chem. Biol. Interact. 2017, 262, 69. [158] L. Fan, H. Ge, S. Zou, Y. Xiao, H. Wen, Y. Li, H. Feng, M. Nie, Int. J. Biol. Macromol. 2016, 93, 582. [159] Q. Zhang, H. Chi, M. Tang, J. Chen, G. Li, Y. Liu, B. Liu, RSC Adv. 2016, 6, 87258. [160] X. T. Zheng, X. Q. Ma, C. M. Li, J. Colloid Interface Sci. 2016, 467, 35. [161] Y. H. Park, S. Y. Park, I. In, J. Indust. Eng. Chem. 2015, 30, 190. [162] a) Q. Pan, Y. Lv, G. R. Williams, L. Tao, H. Yang, H. Li, L. Zhu, Car-\nbohydr. Polym. 2016, 151, 812; b) Y. Lv, L. Tao, S. A. Bligh, H. Yang, Q. Pan, L. Zhu, Mater. Sci. Eng.: C 2016, 59, 652. [163] W. Chen, X. Wen, G. Zhen, X. Zheng, RSC Adv. 2015, 5, 69307. [164] L. Guo, H. Shi, H. Wu, Y. Zhang, X. Wang, D. Wu, L. An, S. Yang,\nCarbon 2016, 107, 87. [165] A. Pourjavadi, Z. M. Tehrani, S. Jokar, Polymer 2015, 76, 52. [166] S. Dinda, M. Kakran, J. Zeng, T. Sudhaharan, S. Ahmed, D. Das,\nS. T. Selvan, ChemPlusChem 2016, 81, 100. [167] M. Wojtoniszak, K. Urbas, M. Perużyńska, M. Kurzawski,\nM. Droździk, E. Mijowska, Chem. Phys. Lett. 2013, 568, 151. [168] L. Du, S. Suo, D. Luo, H. Jia, Y. Sha, Y. Liu, J. Nanopart. Res. 2013,\n15, 1708. [169] Z. Xu, S. Wang, Y. Li, M. Wang, P. Shi, X. Huang, ACS Appl. Mater.\nInterfaces 2014, 6, 17268. [170] H. Kim, R. Namgung, K. Singha, I.-K. Oh, W. J. Kim, Bioconjugate\nChem. 2011, 22, 2558. [171] H. Kim, J. Kim, M. Lee, H. C. Choi, W. J. Kim, Adv. Healthcare\nMater. 2016, 5, 1918. [172] J. T. Robinson, S. M. Tabakman, Y. Liang, H. Wang, H. Sanchez\nCasalongue, D. Vinh, H. Dai, J. Am. Chem. Soc. 2011, 133, 6825. [173] O. Akhavan, E. Ghaderi, Small 2013, 9, 3593.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (35 of 36)\nAdv. Healthcare Mater. 2017, 1700574\n[174] J. Yu, Y. H. Lin, L. Yang, C. C. Huang, L. Chen, W. C. Wang, G. W. Chen, J. Yan, S. Sawettanun, C. H. Lin, Adv. Healthcare Mater. 2016, 6, 1600804. [175] D.-K. Lim, A. Barhoumi, R. G. Wylie, G. Reznor, R. S. Langer, D. S. Kohane, Nano Lett. 2013, 13, 4075. [176] C. Hou, H. Quan, Y. Duan, Q. Zhang, H. Wang, Y. Li, Nanoscale 2013, 5, 1227. [177] F. Wang, Q. Sun, B. Feng, Z. Xu, J. Zhang, J. Xu, L. Lu, H. Yu, M. Wang, Y. Li, Adv. Healthcare Mater. 2016, 5, 2227. [178] D. Hu, J. Zhang, G. Gao, Z. Sheng, H. Cui, L. Cai, Theranostics 2016, 6, 1043. [179] S. Gao, L. Zhang, G. Wang, K. Yang, M. Chen, R. Tian, Q. Ma, L. Zhu, Biomaterials 2016, 79, 36. [180] L.-S. Lin, X. Yang, G. Niu, J. Song, H.-H. Yang, X. Chen, Nanoscale 2016, 8, 2116. [181] a) S. Goenka, V. Sant, S. Sant, J. Controlled Release 2014, 173, 75; b) N. Dubey, R. Bentini, I. Islam, T. Cao, A. H. Castro Neto, V. Rosa, Stem Cells Int. 2015, 2015. [182] W. C. Lee, C. H. Y. Lim, H. Shi, L. A. Tang, Y. Wang, C. T. Lim, K. P. Loh, ACS Nano 2011, 5, 7334. [183] J. Lu, Y. S. He, C. Cheng, Y. Wang, L. Qiu, D. Li, D. Zou, Adv. Funct. Mater. 2013, 23, 3494. [184] O. Akhavan, E. Ghaderi, M. Shahsavar, Carbon 2013, 59, 200. [185] a) H. Liu, J. Cheng, F. Chen, D. Bai, C. Shao, J. Wang, P. Xi,\nZ. Zeng, Nanoscale 2014, 6, 5315; b) H. Liu, J. Cheng, F. Chen, F. Hou, D. Bai, P. Xi, Z. Zeng, ACS Appl. Mater. Interfaces 2014, 6, 3132; c) X. Xie, K. Hu, D. Fang, L. Shang, S. D. Tran, M. Cerruti, Nanoscale 2015, 7, 7992. [186] S. Shah, P. T. Yin, T. M. Uehara, S. T. D. Chueng, L. Yang, K. B. Lee, Adv. Mater. 2014, 26, 3673. [187] a) M. Tang, Q. Song, N. Li, Z. Jiang, R. Huang, G. Cheng, Biomaterials 2013, 34, 6402; b) F. Veliev, A. Briançon-Marjollet, V. Bouchiat, C. Delacour, Biomaterials 2016, 86, 33. [188] a) Y. Dong, J. Cai, X. You, Y. Chi, Analyst 2015, 140, 7468; b) Y. Wang, A. Hu, J. Mater. Chem. C 2014, 2, 6921. [189] a) J. Shen, Y. Zhu, X. Yang, C. Li, Chem. Commun. 2012, 48, 3686; b) J.-L. Li, B. Tang, B. Yuan, L. Sun, X.-G. Wang, Biomaterials 2013, 34, 9519; c) Z. Fan, S. Li, F. Yuan, L. Fan, RSC Adv. 2015, 5, 19773. [190] L. Zhang, Z.-Y. Zhang, R.-P. Liang, Y.-H. Li, J.-D. Qiu, Anal. Chem. 2014, 86, 4423. [191] Z.-b. Qu, X. Zhou, L. Gu, R. Lan, D. Sun, D. Yu, G. Shi, Chem. Commun. 2013, 49, 9830. [192] S. Kiran, R. Misra, J. Biomedical Mater. Res. A 2015, 103, 2888. [193] A. S. Krishna, P. A. Nair, C. Radhakumary, K. Sreenivasan, Mater.\nRes. Express 2016, 3, 055001. [194] P. Shen, Y. Xia, Anal. Chem. 2014, 86, 5323. [195] Y. He, X. Wang, J. Sun, S. Jiao, H. Chen, F. Gao, L. Wang, Anal.\nChim. Acta 2014, 810, 71. [196] L. Zhang, D. Peng, R. P. Liang, J. D. Qiu, Chem. Eur. J. 2015, 21,\n9343. [197] H. Wang, J. Yi, D. Velado, Y. Yu, S. Zhou, ACS Appl. Mater. Inter-\nfaces 2015, 7, 15735. [198] J. Zhang, M. Yang, C. Li, N. Dorh, F. Xie, F.-T. Luo, A. Tiwari,\nH. Liu, Biosensors 2015, 24, 31. [199] H. Miao, L. Wang, Y. Zhuo, Z. Zhou, X. Yang, Biosens. Bioelectron.\n2016, 86, 83. [200] H. Chen, Y. Xie, A. M. Kirillov, L. Liu, M. Yu, W. Liu, Y. Tang, Chem.\nCommun. 2015, 51, 5036. [201] J. Ryu, E. Lee, K. Lee, J. Jang, J. Mater. Chem. B 2015, 3, 4865. [202] I. Al-Ogaidi, H. Gou, Z. P. Aguilar, S. Guo, A. K. Melconian,\nA. K. A. Al-Kazaz, F. Meng, N. Wu, Chem. Commun. 2014, 50, 1344. [203] S. Li, J. Luo, X. Yang, Y. Wan, C. Liu, Sens. Actuat. B: Chemical 2014, 197, 43.\n[204] H. Yang, W. Liu, C. Ma, Y. Zhang, X. Wang, J. Yu, X. Song, Electrochim. Acta 2014, 123, 470. [205] A. Salinas-Castillo, M. Ariza-Avidad, C. Pritz, M. CamprubíRobles, B. Fernández, M. J. Ruedas-Rama, A. Megia-Fernández, A. Lapresta-Fernández, F. Santoyo-Gonzalez, A. Schrott-Fischer, Chem. Commun. 2013, 49, 1103. [206] Y. Lin, C. Wang, L. Li, H. Wang, K. Liu, K. Wang, B. Li, ACS Appl. Mater. Interfaces 2015, 7, 27262. [207] a) Y. Hou, Q. Lu, J. Deng, H. Li, Y. Zhang, Anal. Chim. Acta 2015, 866, 69; b) Q. Xu, J. Zhao, Y. Liu, P. Pu, X. Wang, Y. Chen, C. Gao, J. Chen, H. Zhou, J. Mater. Science 2015, 50, 2571; c) Q. Xu, P. Pu, J. Zhao, C. Dong, C. Gao, Y. Chen, J. Chen, Y. Liu, H. Zhou, J. Mater. Chem. A 2015, 3, 542; d) L. Li, B. Yu, T. You, Biosens. Bioelectron. 2015, 74, 263; e) Y. Dong, G. Li, N. Zhou, R. Wang, Y. Chi, G. Chen, Anal. Chem. 2012, 84, 8378; f) L. Zhou, Y. Lin, Z. Huang, J. Ren, X. Qu, Chem. Commun. 2012, 48, 1147; g) K. Qu, J. Wang, J. Ren, X. Qu, Chem. Eur. J. 2013, 19, 7243; h) W. Lu, X. Qin, S. Liu, G. Chang, Y. Zhang, Y. Luo, A. M. Asiri, A. O. Al-Youbi, X. Sun, Anal. Chem. 2012, 84, 5351; i) A. Zhao, C. Zhao, M. Li, J. Ren, X. Qu, Anal. Chim. Acta 2014, 809, 128; j) W. Wei, C. Xu, J. Ren, B. Xu, X. Qu, Chem. Commun. 2012, 48, 1284; k) A. Gupta, A. Chaudhary, P. Mehta, C. Dwivedi, S. Khan, N. C. Verma, C. K. Nandi, Chem. Commun. 2015, 51, 10750; l) C. Wang, C. Wang, P. Xu, A. Li, Y. Chen, K. Zhuo, J. Mater. Sci. 2016, 51, 861. [208] B. Kong, A. Zhu, C. Ding, X. Zhao, B. Li, Y. Tian, Adv. Mater. 2012, 24, 5844. [209] C. H. Park, H. Yang, J. Lee, H.-H. Cho, D. Kim, D. C. Lee, B. J. Kim, Chem. Mater. 2015, 27, 5288. [210] J. Wang, S. Su, J. Wei, R. Bahgi, L. Hope-Weeks, J. Qiu, S. Wang, Physica E: Low-dimensional Syst. Nanostructures 2015, 72, 17. [211] a) J. Jana, M. Ganguly, T. Pal, PCCP 2015, 17, 2394; b) J. Deng, Q. Lu, Y. Hou, M. Liu, H. Li, Y. Zhang, S. Yao, Anal. Chem. 2015, 87, 2195. [212] L. Zhu, G. Xu, Q. Song, T. Tang, X. Wang, F. Wei, Q. Hu, Sens. Actuat. B: Chemical 2016, 231, 506. [213] W. Kong, D. Wu, G. Li, X. Chen, P. Gong, Z. Sun, G. Chen, L. Xia, J. You, Y. Wu, Talanta 2017, 165, 677. [214] G. Liu, Z. Chen, X. Jiang, D.-Q. Feng, J. Zhao, D. Fan, W. Wang, Sens. Actuat. B: Chemical 2016, 228, 302. [215] Y. Xu, X. Chen, R. Chai, C. Xing, H. Li, X.-B. Yin, Nanoscale 2016, 8, 13414. [216] S. Pang, Y. Zhang, C. Wu, S. Feng, Sens. Actuat. B: Chemical 2016, 222, 857. [217] P. Ni, H. Dai, Z. Li, Y. Sun, J. Hu, S. Jiang, Y. Wang, Z. Li, Talanta 2015, 144, 258. [218] T. T. Bui, S.-Y. Park, Green Chem. 2016, 18, 4245. [219] S. H. Qaddare, A. Salimi, Biosens. Bioelectron. 2017, 89, 773. [220] Q. Huang, X. Lin, J.-J. Zhu, Q.-X. Tong, Biosens. Bioelectron. 2017, 94, 507. [221] S. Nandi, M. Ritenberg, R. Jelinek, Analyst 2015, 140, 4232. [222] S. Bhattacharya, S. Nandi, R. Jelinek, RSC Adv. 2017, 7, 588. [223] M. L. Bhaisare, G. Gedda, M. S. Khan, H.-F. Wu, Anal. Chim. Acta 2016, 920, 63. [224] Q. Wang, X. Huang, Y. Long, X. Wang, H. Zhang, R. Zhu, L. Liang, P. Teng, H. Zheng, Carbon 2013, 59, 192. [225] C. Liu, P. Zhang, X. Zhai, F. Tian, W. Li, J. Yang, Y. Liu, H. Wang, W. Wang, W. Liu, Biomaterials 2012, 33, 3604. [226] Q. Wang, C. Zhang, G. Shen, H. Liu, H. Fu, D. Cui, J. Nanobiotechnology 2014, 12, 58. [227] H. Ding, F. Du, P. Liu, Z. Chen, J. Shen, ACS Appl. Mater. Interfaces\n2015, 7, 6889.\n© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim1700574 (36 of 36)\nAdv. Healthcare Mater. 2017, 1700574\n[228] J. Xu, F. Zeng, H. Wu, C. Hu, C. Yu, S. Wu, Small 2014, 10, 3750. [229] S. Nandi, R. Malishev, K. P. Kootery, Y. Mirsky, S. Kolusheva, R. Jelinek, Chem. Commun. 2014, 50, 10299. [230] K. Jiang, S. Sun, L. Zhang, Y. Lu, A. Wu, C. Cai, H. Lin, Angew. Chem. Int. Ed. 2015, 54, 5360. [231] J. Tang, B. Kong, H. Wu, M. Xu, Y. Wang, Y. Wang, D. Zhao, G. Zheng, Adv. Mater. 2013, 25, 6569. [232] S. K. Bhunia, A. Saha, A. R. Maity, S. C. Ray, N. R. Jana, Sci. Rep. 2013, 3, 1473. [233] S. K. Bhunia, A. R. Maity, S. Nandi, D. Stepensky, R. Jelinek, ChemBioChem 2016, 17, 614. [234] M. Zheng, S. Ruan, S. Liu, T. Sun, D. Qu, H. Zhao, Z. Xie, H. Gao, X. Jing, Z. Sun, ACS Nano 2015, 9, 11455. [235] A. B. Bourlinos, A. Bakandritsos, A. Kouloumpis, D. Gournis, M. Krysmann, E. P. Giannelis, K. Polakova, K. Safarova, K. Hola, R. Zboril, J. Mater. Chem. 2012, 22, 23327. [236] J. Wang, Z. Zhang, S. Zha, Y. Zhu, P. Wu, B. Ehrenberg, J.-Y. Chen, Biomaterials 2014, 35, 9372. [237] J. Ge, M. Lan, B. Zhou, W. Liu, L. Guo, H. Wang, Q. Jia, G. Niu, X. Huang, H. Zhou, Nat. Commun. 2014, 5, 4596. [238] NIH, USA, Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions, http://clinicaltrials.gov/ct2/show/record/NCT01773850. [239] NIH, USA, Diagnosis of Gastric Lesions With Na-nose, http://clinicaltrials.gov/ct2/show/study/NCT01420588. [240] a) A. A. Shvedova, A. Pietroiusti, B. Fadeel, V. E. Kagan, Toxicol. Appl. Pharmacol. 2012, 261, 121; b) H. Y. Mao, S. Laurent, W. Chen, O. Akhavan, M. Imani, A. A. Ashkarran, M. Mahmoudi, Chem. Rev. 2013, 113, 3407. [241] a) O. Salihoglu, S. Balci, C. Kocabas, Appl. Phys. Lett. 2012, 100, 213110; b) L. Wang, K. Y. Pu, J. Li, X. Qi, H. Li, H. Zhang, C. Fan, B. Liu, Adv. Mater. 2011, 23, 4386. [242] L. Feng, Z. Liu, Nanomedicine 2011, 6, 317. [243] W. Zhang, Z. Guo, D. Huang, Z. Liu, X. Guo, H. Zhong, Biomaterials 2011, 32, 8555. [244] Z. Liu, J. T. Robinson, S. M. Tabakman, K. Yang, H. Dai, Mater. Today 2011, 14, 316. [245] A. Battigelli, C. Ménard-Moyon, T. Da Ros, M. Prato, A. Bianco, Adv. Drug Delivery Revs. 2013, 65, 1899. [246] a) F. T. Andón, A. A. Kapralov, N. Yanamala, W. Feng, A. Baygan, B. J. Chambers, K. Hultenby, F. Ye, M. S. Toprak, B. D. Brandner, Small 2013, 9, 2721; b) J. Russier, C. Ménard-Moyon, E. Venturelli, E. Gravel, G. Marcolongo, M. Meneghetti, E. Doris, A. Bianco, Nanoscale 2011, 3, 893. [247] G. P. Kotchey, B. L. Allen, H. Vedala, N. Yanamala, A. A. Kapralov, Y. Y. Tyurina, J. Klein-Seetharaman, V. E. Kagan, A. Star, ACS Nano 2011, 5, 2098. [248] a) Y. Sato, A. Yokoyama, Y. Nodasaka, T. Kohgo, K. Motomiya, H. Matsumoto, E. Nakazawa, T. Numata, M. Zhang, M. Yudasaka, Sci. Rep. 2013, 3, 2516; b) C. M. Girish, A. Sasidharan, G. S. Gowd, S. Nair, M. Koyakutty, Adv. Healthcare Mater. 2013, 2, 1489; c) A. Nunes, C. Bussy, L. Gherardini, M. Meneghetti, M. A. Herrero, A. Bianco, M. Prato, T. Pizzorusso, K. T. Al-Jamal, K. Kostarelos, Nanomedicine 2012, 7, 1485. [249] L. Liu, C. Zhu, M. Fan, C. Chen, Y. Huang, Q. Hao, J. Yang, H. Wang, D. Sun, Nanoscale 2015, 7, 13619. [250] V. E. Kagan, N. V. Konduru, W. Feng, B. L. Allen, J. Conroy, Y. Volkov, I. I. Vlasova, N. A. Belikova, N. Yanamala, A. Kapralov, Nat. Nanotechnol. 2010, 5, 354. [251] N. Lu, J. Li, R. Tian, Y.-Y. Peng, Chem. Res. Toxicol. 2014, 27, 1070."
    } ],
    "references" : [ {
      "title" : "www.advancedsciencenews.com  www.advhealthmat.de Adv",
      "author" : [ "a) H.-C. Wu", "X. Chang", "L. Liu", "F. Zhao", "Y. Zhao", "J. Mater. Chem" ],
      "venue" : "WILEY-VCH Verlag GmbH & Co. KGaA,",
      "citeRegEx" : "10",
      "shortCiteRegEx" : "10",
      "year" : 2017
    }, {
      "title" : "J",
      "author" : [ "Ş. Alpat", "K. Özdemir", "S. Kılınç Alpat" ],
      "venue" : "Sens. 2016",
      "citeRegEx" : "27",
      "shortCiteRegEx" : null,
      "year" : 2016
    }, {
      "title" : "Int",
      "author" : [ "O. Im", "J. Li", "M. Wang", "L.G. Zhang", "M. Keidar" ],
      "venue" : "J. Nanomed. 2012, 7",
      "citeRegEx" : "95",
      "shortCiteRegEx" : null,
      "year" : 2087
    }, {
      "title" : "Adv",
      "author" : [ "H. Kim", "J. Kim", "M. Lee", "H.C. Choi", "W.J. Kim" ],
      "venue" : "Healthcare Mater. 2016, 5",
      "citeRegEx" : "171",
      "shortCiteRegEx" : null,
      "year" : 1918
    }, {
      "title" : "ACS Nano 2011",
      "author" : [ "G.P. Kotchey", "B.L. Allen", "H. Vedala", "N. Yanamala", "A.A. Kapralov", "Y.Y. Tyurina", "J. Klein-Seetharaman", "V.E. Kagan", "A. Star" ],
      "venue" : "5",
      "citeRegEx" : "247",
      "shortCiteRegEx" : null,
      "year" : 2098
    } ],
    "referenceMentions" : [ {
      "referenceID" : 0,
      "context" : "[9] Attachment of amphiphilic small molecules and polymers has been also reported.[10] Noncovalent functionalization of CNTs is particularly useful as this treatment does not disrupt the carbon lattice, thus generally preserving the physico-chemical properties of CNTs.",
      "startOffset" : 82,
      "endOffset" : 86
    }, {
      "referenceID" : 1,
      "context" : "[24] CNT-based sensors were employed for detection of many other biomolecular targets, including galactose,[25] neurotransmitters (dopamine,[26] epinephrine,[27] and norepinephrine[28]), amino acids (i.",
      "startOffset" : 157,
      "endOffset" : 161
    }, {
      "referenceID" : 2,
      "context" : "[91] CNTs have been examined as useful platforms for improving the mechanical and electrical properties of artificial tissue scaffolds,[92–94] bone regeneration,[95] augmentation,[96] and cell stimulation actuators.",
      "startOffset" : 161,
      "endOffset" : 165
    }, {
      "referenceID" : 2,
      "context" : "In yet another study, incorporating of SWCNTs in gelatin/chitosan solutions improved the conductivity of hydrogels even at very low concentrations (<100 ppm), thereby aiding signal transmission, promoting functional maturation and synchronous beating of the cardiomyocytes.[95] Specifically, 3D porous chitosan frameworks with different contents of nanocrystalline hydroxyapatite and SWCNTs were fabricated to support the growth of human osteoblasts (bone-forming cells).",
      "startOffset" : 273,
      "endOffset" : 277
    }, {
      "referenceID" : 2,
      "context" : "Two types of SWCNTs were synthesized through arc discharge, with a magnetic field (B-SWCNT) and without (N-SWCNT), and were utilized for improved bone regeneration.[95] The presence of B-SWCNTs in chitosan nanocomposite had a considerable effect on osteoblast attachment and bone regeneration.",
      "startOffset" : 164,
      "endOffset" : 168
    }, {
      "referenceID" : 3,
      "context" : "or electrostatic interactions with varied cationic polymers and employed for delivery of plasmid DNA (pDNA).[171]",
      "startOffset" : 108,
      "endOffset" : 113
    }, {
      "referenceID" : 4,
      "context" : "[245] On a cellular level, a degradation process has been demonstrated for carbon nanotubes[246] and graphene.[247] Very few studies are currently available on the capacity of phagocytic cells or specific tissues to induce carbon nanomaterial degradation following in vivo administration in animal models.",
      "startOffset" : 110,
      "endOffset" : 115
    } ],
    "year" : 2017,
    "abstractText" : "Carbon nanostructures have had a tremendous impact in scientific research and technology progress. The unifying property of zero-dimension fullerenes,[1] one dimensional carbon nanotubes (CNTs),[2] the two-dimensional carbon allotrope graphene[3] and recently synthesized carbon quantum dots[4] is the sp2-bonded carbon atoms that are generally arranged in hexagonal lattices. These features, combined with the interesting electrical, chemical, and mechanical properties of carbon nanomaterials, have led to numerous applications in diverse fields. The potential of carbon nanomaterials in biology–e.g., as conduits for biosensing, bioimaging, and as novel biomimetic materials–has been recognized early on. While carbon nanomaterials have been initially used in biosensing and as potential drug carriers, recent years saw expansion of their applications into regenerative medicine, tissue engineering, bioimaging, and therapeutics. Reviews discussing biological applications of CNTs,[5] graphene,[6] and carbon quantum dots[7,8] have been published. This Review focuses on biologically oriented applications of the three main families of carbon nanostructures–CNTs, graphene (pristine graphene, graphene oxide, and reduced graphene oxide), and carbon quantum dots. Figure 1 presents an outline of the contents of this Review article. Our goal is to provide a broad overview of the diverse applications of these nanomaterials, emphasizing the significance of their respective The “carbon nano-world” has made over the past few decades huge contributions in diverse scientific disciplines and technological advances. While dramatic advances have been widely publicized in using carbon nanomaterials such as fullerenes, carbon nanotubes, and graphene in materials sciences, nano-electronics, and photonics, their contributions to biology and biomedicine have been noteworthy as well. This Review focuses on the use of carbon nanotubes (CNTs), graphene, and carbon quantum dots [encompassing graphene quantum dots (GQDs) and carbon dots (C-dots)] in biologically oriented materials and applications. Examples of these remarkable nanomaterials in bio-sensing, celland tissue-imaging, regenerative medicine, and other applications are presented and discussed, emphasizing the significance of their unique properties and their future potential. Carbon Nanomaterials",
    "creator" : "Adobe InDesign CS6 (Macintosh)"
  }
}